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ABSTRACT 
 
Assaying Protein Import into Mitochondria Using 
 
Fluorescence Spectroscopy. (May 2006) 
 
Holly Beth Cargill, B.S., University of Nebraska – Lincoln 
 
Chair of Advisory Committee:  Dr. Arthur E. Johnson 
 
 
 
 Most proteins residing in the mitochondrial matrix are synthesized in the cytosol 
and post-translationally imported into the mitochondrial matrix.  The matrix-targeted 
preproteins traverse the outer mitochondrial membrane (OM) via the Translocase of the 
Outer Membrane (TOM) complex, and the inner mitochondrial membrane (IM) via the 
Translocase of the Inner Membrane 23 (TIM23) complex.  A novel system was set up to 
examine the import of matrix-targeted preproteins into mitochondria using fluorescence 
spectroscopy.  The fluorescent probe 6-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)aminohexanoic acid (NBD) was site-specifically incorporated into different positions 
along the model matrix protein Su9-DHFR. The fluorescent-labeled polypeptides were 
either fully imported into isolated mitochondria or were arrested along the translocation 
pathway by the binding of methotrexate (MTX) to the DHFR moiety, creating NBD-
Su9-DHFR•MTX import intermediates.  The NBD-Su9-DHFR polypeptides were able 
to be fully imported into the mitochondrial matrix in the absence of MTX, and were 
inaccessible to externally-added iodide ion quenchers.  Treatment of the mitochondria 
with the pore-forming antibiotic alamethicin allowed the iodide ion quenchers access to 
the matrix through pores in the inner membrane (IM).  After Alamethicin treatment the 
 iv
fully-imported NBD-Su9-DHFR polypeptides were accessible to the externally-added 
iodide ions.  The extent of collisional quenching of the NBD fluorophores by the iodide 
ions was measured as the Stern-Volmer quenching constant, Ksv.  Ksv values were 
obtained for the NBD-Su9-DHFR polypeptides in the presence of MTX (import 
intermediates) or in the absence of MTX (fully-imported).  The Ksv values for NBD-Su9-
DHFR import intermediates were similar, despite the location of the NBD probe along 
the translocation pathway.  These Ksv values were similar to those obtained for the fully-
imported NBD-Su9-DHFR polypeptides (-MTX).  The locations of the varying probe 
positions along the import pathway were addressed using chemical crosslinking of Su9-
DHFR Cys mutants.  The use of fluorescence spectroscopy, in association with chemical 
crosslinking, to analyze the mitochondrial protein import pathways will prove a useful 
tool to probe the environment of the nascent chain as it is crossing the import pathway 
(the TOM, TIM23 complexes). 
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CHAPTER I 
INTRODUCTION 
 
 
The Mitochondrion 
 
 The mitochondrion is the organelle responsible for energy generation in most 
eukaryotic cells.  Mitochondria are complex organelles, believed to be descendants of a 
eubacterium that have evolved to become the major cellular source of ATP regeneration 
through respiration.  Unlike most other organelles, the mitochondrial lumen, or matrix, is 
surrounded by two distinct membranes, termed the outer membrane (OM) and inner 
membrane (IM).  The aqueous space between the OM and IM is called the 
intermembrane space (IMS) (Figure I-1).  The IM is the location for the complexes 
involved in electron transport, as well as translocators for ATP, NADH, PO42-, and many 
other small molecules.  The coupling of electron transport and ATP synthesis generates a 
proton electrochemical gradient across the IM.  To maximize the density of the proteins 
involved in oxidative metabolism, the IM has a large surface area that is folded into tight 
cristae, surrounded by the OM. 
 Mitochondria have long been known to be the site for electron transport and ATP 
synthesis (IM), the citric acid cycle (matrix), the heme cycle (matrix), and heme 
biosynthesis (IM, IMS) (Tzagoloff, 1982).  The mitochondrion has also been implicated 
in apoptosis, or programmed cell death (Adrain and Martin, 2001).  Mitochondria also  
____________ 
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contain their own DNA, ribosomes, and translation machinery; however, the genome 
codes for only eight distinct proteins in yeast, which means that 99% of all 
mitochondrial proteins are synthesized in the cytosol and imported post-translationally 
into the organelle (Sickmann et al, 2003).   
With all such important metabolic pathways housed in the mitochondrion, the 
necessity for correct targeting of mitochondrial proteins becomes obvious.  To achieve 
this, mitochondria have multiple import pathways to correctly translocate soluble 
proteins to the matrix/IMS and to insert a membrane protein into its target membrane 
(Figure I-2).  In addition, cytosolic chaperones aid in delivery of the nascent proteins to 
the organelle, and help to prevent aggregation of any transmembrane domains prior to 
insertion.  The outer membrane houses the Translocase of the Outer Membrane (TOM) 
complex, through which nearly all of the imported proteins travel (Kiebler et al, 1990).  
At this point the pathways diverge.  OM β-barrel proteins, such as Tom40p and the yeast 
porins, are then inserted into the OM via the Sorting and Assembly Machinery (SAM) 
Complex (Wiedemann et al, 2003).  Proteins destined for the IM (often referred to as the 
carrier proteins) contain internal targeting signals that direct them to the Translocase of 
the Inner Membrane (TIM) 22 complex for membrane insertion (Truscott and Pfanner, 
1999).  Matrix-targeted proteins are synthesized in the cytosol with positively charged 
presequences that direct them to the TIM23 complex (Jensen and Dunn, 2002), where 
they are translocated across the IM, with the assistance of the Presequence-Assisted 
Motor (PAM) Complex (Neupert et al, 2003).  All of the proteins coded by the 
mitochondrial genome are IM proteins, inserted into the membrane from the matrix side 
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of the IM via the OXA1 complex (Stuart, 2002).  Each of these translocation complexes 
will be discussed in detail below.  
 
The TOM Complex 
The TOM complex consists of the proteins Tom40, Tom20, Tom22, Tom70, 
Tom5, Tom6, and Tom7, all of which are membrane proteins (Figure I-3).  Tom40 
forms the General Import Pore (GIP) through which almost all proteins targeted to the 
mitochondria will pass, regardless of their differing targeting signals (Kunkele et al, 
1998a; Kiebler 1990; Ahting et al, 1999; Sollner et al, 1992, Hill et al, 1998).  Tom40 is 
believed to form a β-barrel in the OM (Hill et al, 1998; Kunkele et al, 1998a; Ahting et 
al, 2001), with EM data suggesting that each TOM complex contains 2-3 Tom40 pores 
(Kunkele et al, 1998b, Achting et al, 1999).  Work by Esaki et al (2003) has shown that 
Tom40 actively participates in transport by binding to incoming preproteins to prevent 
their aggregation.   
The receptor proteins Tom20, Tom22, and Tom70 receive incoming proteins 
from cytosolic chaperones and transfer them to Tom40.  Tom70 is the receptor for IM-
targeted proteins, and it has been proposed that each Tom70 monomer binds two IM 
transmembrane domains (Söllner et al, 1990; Wiedemann et al, 2001).  Each Tom70 has 
specific binding sites for the incoming carrier protein and for the Hsp70 and Hsp90 
chaperones that bring the precursor protein to the TOM complex (Young et al, 1993).  
Tom20 and Tom22 cooperate to bind the matrix-targeted preproteins.  Tom20 has been 
shown to contain a grove consisting of a hydrophobic face designed to bind the  
 6
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amphipathic α-helix of the matrix targeting presequence, while Tom22 harbors a 
negatively charged surface to interact with the positively charged surface (Bollinger et 
al, 1995; Nargang et al, 1998; Abe et al, 2000).  In addition, Tom22 also has a negatively 
charged patch on its IMS domain for binding of the precursor protein after it has passed 
through the Tom40 pore (Rapaport et al, 1998).  The small Tom proteins, Tom5, Tom6, 
and Tom7, together modulate the structural stability of the TOM complex (Dembowski 
et al, 2001; Dietmeier et al, 1997; Schmitt et al, 2005).     
 
The SAM Complex 
The SAM complex (also referred to as the TOB complex (Paschen et al, 2003)) is 
the most recently discovered mitochondrial translocase, and is required for insertion of 
β-barrel proteins into the mitochondrial OM (Figure I-3).  The SAM complex was first 
identified by analyzing the role of Mas37: mitochondria lacking Mas37 are deficient in 
import of OM β-barrel proteins, such as porin and Tom40, while import of all other 
mitochondrial proteins proceeds as in the wild-type strain (Wiedemann et al, 2003). 
More subunits of the SAM complex were later identified, including Sam50 
(Tob55/Omp85), Tom13 and Sam35/Tom38 (Kozjak et al, 2003; Paschen et al, 2003; 
Gentle et al, 2004; Milenkovic et al, 2004; Ishikawa et al, 2004).  While the exact 
mechanism for insertion of β-barrel proteins by the SAM complex is unknown, it 
appears that these proteins first pass through the Tom40 pore to the IMS, where they are 
presented to the trans side of the membrane for subsequent insertion (Voulhoux et al, 
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2003).  This approach mimics that for protein integration into the bacterial OM, 
suggesting that this pathway is highly conserved thoughout evolution.  
 
The TIM22 Complex 
 The TIM22 complex is the pathway used to insert polytopic IM proteins, such as 
the ADP/ATP Carrier (AAC), the Inorganic Phosphate Carrier (PiC), and Tim23p.  
Proteins destined for this pathway contain no cleavable targeting sequences, but rather 
have internal targeting signals that direct them to the TIM22 complex (Wiedemann et al, 
2001; Endres et al, 1999; Davis et al, 1998; Davis et al, 2000).  The TIM22 complex is 
made up of inner membrane proteins Tim22, Tim18, and Tim54, as well as the 
peripheral membrane protein Tim12 (Sirrenberg et al, 1996, Kerscher et al, 1997, 
Koehler et al, 2000, Kerscher et al, 2000)  (Figure I-4).  Previous work has shown that 
polytopic IM proteins traverse the OM in a partially folded conformation, and are then 
bound in the IMS by small Tim proteins, Tim9•Tim10 and, in some cases (Tim23, for 
example), Tim8•Tim13 (Koehler et al, 1998; Sirrenberg et al, 1998; Davis et al, 1998; 
Davis et al, 2000).  The Tim9•Tim10 and Tim8•Tim13 complexes then docks with 
Tim12, delivering the incoming carrier protein to the TIM22 complex. Little is known 
about the exact roles of Tim18 and Tim54.   
Electrophysiological data showed that Tim22 to forms a pore in the IM 
(Kovermann et al, 2002).  Subsequent cryo-electron microscopy work on isolated TIM22 
complexes by Rehling et al (2003) revealed that Tim22 forms a “twin-pore” translocase, 
 9
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with each pore having an inner diameter of near 16 Å, approximately large enough to 
allow room for one folded α-helix.  The only energy source required for protein  
 insertion via the TIM22 complex is the membrane potential (∆Ψ) across the IM 
(Pfanner et al, 1985; Pfanner et al, 1987a, b).  Further electrophysiology data also 
revealed that exposure of the internal targeting sequences of the incoming protein to 
Tim22, in the presence of the ∆Ψ, resulted in the rapid closure of one pore and the 
simultaneous opening of the other, thus appearing to activate the gating of the pores 
(Rehling et al, 2003).  
 The small Tim complexes are not directly part of the TIM22 pathway, but have 
been implicated in the biogenesis of OM β-barrel proteins as well as that of polytopic IM 
proteins.  The Tim9•Tim10 complex has been shown to be essential for import of IM 
proteins (Koehler et al, 1998a, b; Sirrenberg et al, 1998) while the Tim8•Tim13 complex 
interacts with IM proteins containing large IMS domains, such as Tim23 (Koehler et al, 
1999; Davis et al, 2000).  Each of the proteins in these small Tim complexes contains a 
zinc-finger motif (Curran et al, 2002a, b; Lutz et al, 2003; Allen et al, 2003; Koehler et 
al, 2004).  Their roles then appear to be to guide membrane proteins across the aqueous 
IMS and prevent aggregation of these proteins prior to insertion.  Recent work by 
Wiedemann et al (2004), and Hoppins et al (2004), has shown the Tim9•Tim10 protein 
complex to be involved in the biogenesis of OM β-barrel proteins as well, probably by 
binding to these proteins to prevent their aggregation in the IMS.  Import of these small 
Tim proteins, and likely other resident IMS proteins, appears to be facilitated by 
Mia40/Tim40 (Chacinska et al, 2004; Naoe et al, 2004, Terziyska et al, 2005).  Mia40, in 
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cooperation with the sulphydryl oxidase Erv1, has been shown to catalyze their import 
into the IMS (Mesecke et al, 2005).        
 
The TIM23 Complex 
 The TIM23 complex is the translocase used by matrix-targeted proteins, and by a 
few IMS and IM proteins.  The majority of proteins traveling this pathway are 
synthesized with an N-terminal, positively charged presequence that is cleaved by matrix 
processing peptidase (MMP) upon entry into the matrix (for review see Luciano and 
Geli, 1996).  The N-terminal preseqence forms an amphipathic α-helix (Wieprecht et al, 
2000; Roise et al, 1998; von Heijne, 1986) that has been shown to be sufficient to direct 
a protein to the mitochondria (Hurt et al, 1984; Horwich et al, 1985).  In addition to the 
cleaveable presequence, the TIM23 complex also recognizes preproteins containing a 
hydrophobic signal anchor, for targeting to the IM, as well as proteins containing a 
bipartite presequence that consists of a matrix presequence followed by a hydrophobic 
sorting signal, for targeting to the IMS (Glick et al, 1992; Hahne et al, 1994; Gartner et 
al, 1995, Schneider et al, 1991; Nunnari et al, 1993).   
 The TIM23 complex is made up of four essential IM proteins:  Tim23, Tim17, 
Tim50, and Tim21 (Figure I-5).  Electrophysiological experiments on purified Tim23 
have indicated that it is the pore-forming subunit of the TIM23 complex, with an 
aqueous pore of between 13 and 24 Å wide (Truscott et al, 2001).  These experiments 
support earlier data by Schwartz and Matousek (1999) that attempted to address the pore 
size of the TIM23 complex using 19 and 26 Å gold particles attached to model matrix  
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proteins, and found that only the 19 Å gold particles could be successfully imported into 
the matrix.  Tim23 is composed of two domains: an N-terminal domain that resides in 
the IMS, and a C-terminal domain composed of four transmembrane α-helices that 
resides in the IM (Dekker et al, 1993; Emtage and Jensen, 1993).  The C-terminal 
domain is the pore-forming domain, while the N-terminal domain modulates interactions 
with the incoming presequences (Bauer et al, 1996; Truscott et al, 2001).  Tim17 is 
structurally similar to the C-terminal domain of Tim23, but cannot complement a Tim23 
deletion (Maarse et al, 1994, Ryan et al, 1994).  Tim21 and Tim50 both have single 
transmembrane segments, and Tim50 also has a large IMS domain that interacts with 
incoming matrix presequences (Chacinska et al, 2005, Mokranjac et al, 2005, Mokranjac 
et al, 2003, Geissler et al, 2002, Yamamoto et al, 2002).  Tim21 appears to modulate the 
functionality of the TIM23 complex, and will be discussed in more detail below.  
 While it is possible to directly import matrix-targeted preproteins across the IM 
in the absence of the OM and TOM complex (termed mitoplasts; Hwang et al, 1989), it 
is generally believed that the TOM complex and TIM23 complex form a translocase 
contact site through which the matrix proteins travel (Dekker et al, 1997; Donzeau et al, 
2000).  There are patches of negatively-charged residues on the cis and trans side of 
Tom22, as well as Tim50, that appear to interact with the positively-charged side of the 
N-terminal presequence, driving translocation across the OM and to the cis side of the 
TIM23 complex (Bollinger et al, 1995).  This phenomenon of protein translocation via 
interactions of a positively-charged protein domain with proteins of increasing negative 
charges is referred to as the acid chain hypothesis (Schatz et al, 1996).  After 
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translocation across the OM, the presequence is believed to trigger opening of the Tim23 
pore by an interaction with its IMS domain (Bauer et al, 1996, Truscott et al, 2001).  The 
presequence then crosses the IM in a ∆Ψ-dependent manner, where it is pulled across 
the IM and into the matrix by the PAM complex, which will be described below 
(Pfanner et al, 1987a; Martin et al, 1991; Kanamori et al, 1999).  
 Tim21 is the most recently discovered subunit of the TIM23 complex.  It appears 
to bind to the trans side of Tom22, further linking the TOM and TIM23 complexes 
(Chacinska et al, 2005, Mokranjac et al, 2005).  After the incoming presequence binds to 
Tom22, Tim21 dislodges the presequence and allows it to be transferred to the Tim23 
channel (Chacinska et al, 2005).  This occurs because Tim21 completes with the same 
binding site on Tom22 as the incoming preprotein.  An extension of this work found that 
Tim21 appears to then disassociate from the TIM23 complex, allowing for association of 
the PAM channel and subsequent translocation of the entire preprotein across the IM. 
Binding of both Tim21 and the PAM Complex to the TIM23 complex appears to occur 
through Tim17 and both likely compete for the same binding site (Chacinska et al, 2005, 
Murcha et al, 2005).   
 The discovery of these two different states of TIM23 (Tim21 bound or PAM 
bound) brings forward a means of separating the protein translocation and protein 
insertion functions of the TIM23 complex.  While Tim21 is bound and PAM is not 
bound (or is more loosely associated), protein translocation cannot occur, setting up an 
ideal situation for protein insertion, which is a much less studied aspect of the TIM23 
complex.   
 15
The PAM Complex 
 The PAM complex associates with the TIM23 complex during protein 
translocation and functions to pull the incoming matrix preprotein across the IM and into 
the matrix.  It consists of the peripheral membrane protein Tim44, the chaperone 
mtHsp70/Ssc1 and its nucleotide exchange factor Mge1, and three co-chaperones 
Pam16, Pam17, and Pam18/Tim14 (Figure 1-6).  Tim44 interacts with both Tim23 and 
mtHsp70, and is believed to recruit the matrix chaperone to the TIM23 complex so that 
it can exert its pulling effect on the incoming preprotein (Schneider et al, 1994, Merlin et 
al, 1999, Moro et al, 2002; D’Silva et al, 2003, D’Silva et al, 2004).  The ability of 
mtHsp70 to pull the incoming preprotein across the IM requires successive rounds of 
ATP-hydrolysis, assisted by Pam16, Pam18, and Mge1.  Pam18, being a member of the 
J domain family, stimulates the ATPase activity of mtHsp70, while Pam16 helps to 
recruit Pam18 to the TIM23 complex, keeping the PAM complex near the presequence 
translocase (Truscott et al, 2003; D’Silva et al, 2003; Kozany et al, 2004; Frazier et al, 
2004).  Pam17, the most recently discovered subunit of the complex, appears to be 
required for association of Pam16 and Pam18 with the TIM23 complex (van der Laan et 
al, 2005).    
Ssc1, being a member of the heat shock protein family, contains two separate 
domains, a peptide binding domain and a nucleotide-binding domain (Craig et al, 1989).  
In the presence of ATP, Ssc1 has a high affinity for both the presequence and Tim44,  
 16
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which allows the chaperone to be in the proper position on the matrix side of the TIM23 
channel to bind the translocating preprotein (Schneider et al, 1994; Moro et al, 2002;  
Strub et al, 2002; D’Silva et al, 2004).  This binding of the preprotein by mtHsp70 
results in dissociation from Tim44, which causes Ssc1 to dislocate from the TIM23 
complex (Geissler et al, 2001; Liu et al, 2003).  The “free” Ssc1 molecule takes with it 
the incoming polypeptide, bound tightly enough to prevent retrograde translocation back 
into the channel (Ungermann et al, 1994; Ungermann et al, 1996).  An exchange of ADP 
for ATP by the nucleotide exchange factor Mge1 would then allow mtHsp70 to 
dissociate from the substrate polypeptide.  Dislocation of one Ssc1 molecule from the 
TIM23 complex allows for a second molecule to bind the next segment of the incoming 
polypeptide, repeating the cycle until the polypeptide is transported entirely across the 
IM and into the matrix.  
 Much of the early literature concerning Ssc1 centered on whether the action of 
mtHsp70 on the incoming preprotein constitutes a “trapping” or “pulling” force.  
However, it has since been discovered that both roles can be given to the chaperone.  
Binding of the presequence by mtHsp70 can be considered a “trapping” force, in that it 
prevents diffusion of the matrix preprotein back up into the cytosol.  Dislocation of the 
peptide-bound mtHsp70 away from the TIM23 complex comprises a “pulling” force in 
that it physically draws the peptide further into the matrix.  These separate roles can be 
described to separate functions of Ssc1:  interaction of mtHsp70 with the preprotein via 
the Ssc1 peptide-binding domain, and interaction with the membrane anchor Tim44.  
 18
Mutations in these different domains of mtHsp70 appear to modulate the two functions 
distinctly (Voisine et al, 1999).    
 
The OXA Complex 
 The OXA complex is located in the IM, and serves to insert inner membrane 
proteins from the matrix side of the IM.  The Oxa1 protein (to date the only known 
protein of the complex) was originally discovered as being required for formation of 
cytochrome c oxidase (part of Complex IV of the electron transport chain) (Bonnefoy et 
al, 1994; Bauer et al, 1994).  Most of the proteins inserted into the IM via Oxa1 are those 
translated on mitochondrial ribosomes, although some nuclear-encoded proteins are also 
inserted via this pathway (Hell et al, 1997, 1998, 2001).  The Oxa1 protein is a member 
of the Oxa1/YidC/Alb3 family, and appears to function as a dimer or tetramer (Nargang 
et al, 2002).  Consistent with other members of the family, Oxa1 has been shown to 
cotranslationally insert polytopic proteins into the IM, although some IM-targeted 
proteins translated on cytosolic ribosomes are also inserted post-translationally (for 
review see Stuart, 2002).  
 
Current Dogma for Import of Matrix-Targeted Proteins 
 Translocation of matrix preproteins is the most well studied pathway of 
mitochondrial import.  Matrix protein import is believed to be post-translational (Jensen 
and Dunn, 2002), unlike proteins of the ER secretory pathway (for review, see van Waes 
and Johnson, 1999).  In accordance with current data, the import pathway functions as 
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follows: The positively charged presequence directs the protein to the mitochondria, 
aided by cytosolic chaperones, where it engages the TOM complex via the 
Tom22/Tom20 receptors and is subsequently passed through the Tom40 pore.  Once the 
preprotein reaches the IMS, the presequence binds to the IMS domain of Tom22 and 
then moves to the IMS domains of the Tim50 and Tim23.  Binding of the presequence to 
the N-terminal domain of Tim23 results in activation of the Tim23 pore.  In a ∆Ψ-
dependent manner, the presequence crosses the IM via the Tim23 pore and is then bound 
by mtHsp70.  Through successive rounds of ATP hydrolysis, aided by the other 
members of the PAM complex, the entire preprotein is pulled across the IM by the 
mtHsp70 protein, where the mitochondrial processing peptidase (MPP) then cleaves the 
presequence and the matrix chaperones fold the protein into its final conformation (for a 
review on MPP see Gakh et al, 2002).  Removal of the presequence allows the mature 
portion of the matrix protein to be folded, with the aid of chaperones, into its active 
conformation (Figure I-7).   
 As well studied as the pathway is, there are many questions left unanswered.  
While it has been shown that TOM/TIM supercomplexes are formed during the import 
of a matrix preprotein (Dekker et al, 1997), it is as yet unknown whether the preprotein 
is ever exposed to the aqueous IMS.   The Tim23 protein has also been shown to be the 
pore-forming subunit of the TIM23 complex, containing an aqueous pore (Truscott et al, 
2001), but it has not been shown experimentally whether a translocating preprotein 
passes through the IM via this aqueous pore.  It is also unkown how the Tim23 pore is  
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gated during translocation, although this is required to maintain the membrane potential.  
Indeed, membrane depolarization blocks ATP production by the mitochondrion. 
 Each of these questions can be addressed with a fluorescence-based system.  By 
site-specifically labeling a matrix preprotein with fluorescent probes and generating 
import intermediates it would be possible to ascertain the environment of the 
translocating preprotein as it is crossing the OM and IM.  
 
Specific Aims of This Thesis 
 The primary goal of this research project was to develop a fluorescence-based 
system to study protein import into mitochondria.  Previously in the lab, the 
translocation of secretory proteins across the ER membrane was examined using a 
fluorescence-based system whereby nascent secretory proteins (i.e., still attached to the 
translating ribosomes) were site-specifically labeled with fluorescent probes (Crowley et 
al, 1994; Hamman et al, 1997).  These fluorescent ribosome•nascent chain complexes 
(RNCs) were co-translationally targeted to translocons in the ER membrane to form 
translocation intermediates.  Using this approach, the environment and accessibility of 
the fluorophore to different sides of the ER membrane was characterized while the 
nascent chain was positioned within and interacting with the translocation machinery.  
Different stages of translocation were investigated by shortening or lengthening the 
nascent chain, and different portions of the nascent chain were examined.    
Would it be possible to site-specifically label a matrix-targeted protein with a 
fluorescent probe, import the labeled proteins into isolated mitochondria, and analyze the 
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fluorescence signal of the imported proteins?  If so, my original goals were to:  (i) 
determine whether the imported polypeptide is exposed to the aqueous IMS; (ii) whether 
it passes through an aqueous pore in the TIM23 complex; and (iii) if so, bow the the IM 
maintains its permeability barrier during protein import into the matrix.  While the 
difficulties of successfully created and characterizing this new experimental system 
prevented me from achieving these goals, the progress towards the goals described in 
this thesis provides the foundation upon which to build and determine those unknowns.  
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CHAPTER II 
EXPERIMENTAL PROCEDURES 
 
 
Preparation of Lys-tRNAamb 
 A plasmid encoding the wild-type Escherichia coli (E. coli) lysine tRNA gene, a 
gift from Dr. Greg Beckler (Promega, Madison, WI), was used for site-directed 
mutagenesis to change the anticodon loop to CUA, creating an amber suppressor tRNA 
(here termed tRNAamb).  PCR was performed to amplify the region of the plasmid that 
contained the T7 promoter sequence and the in-frame amber suppressor tRNA gene.  An 
in vitro transcription reaction was performed, using the purified PCR products and T7 
RNA polymerase, and incubated at 37°C for at least 4 h.  The resulting tRNA was 
purified by anion exchange chromatography using a Mono Q HR 10/10 column on an 
FPLC (Pharmacia).  The tRNA was eluted in 10 mM NaOAc (pH 4.5), 5 mM MgCl2 
with a 115 mL linear gradient of NaCl from 480 mM to 1 M.  Aminoacylation was 
performed to determine which fractions were enriched in tRNAamb as described 
previously (Crowley et al, 1993; Johnson et al, 1982; Krieg et al, 1989; Krieg et al, 
1986) with the modification that 6 mM MgCl2 and no KCl was used.  The majority of 
the tRNA eluted near 550 mM NaCl and the fractions with the highest functional 
tRNAamb content were aminoacylated with [14C]Lys and stored at –80°C until needed 
(Flanagan et al, 2003).   
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Chemical Modification of [14C]Lys-tRNAamb 
 The side chain amino group of lysine in [14C]Lysine-tRNAamb was preferentially 
reacted with the succinimidyl ester of 6-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)aminohexanoic acid (NBD) to form Nε-NBD-Lys-tRNAamb (εNBD-Lys-tRNAamb) as 
previously described (Johnson et al, 1976; Crowley et al, 1993).  The resultant modified 
[14C]Lys-tRNAamb was purified and its specific activity measured, expressed in units of 
pmol Lys/A260 units of tRNA .  The structure of εNBD-[14C]Lys tRNAamb is shown 
below (Figure II-1). 
 
Preparation of Yeast Mitochondria 
 The Saccharomyces cerevesiae yeast strain D273-10B was a generous gift from 
Dr. Rob Jensen (Johns Hopkins University, Baltimore, Maryland).  The mitochondrial 
isolation protocol was modified from a protocol from Daum et al (1982).  To increase 
the amount of mitochondria per OD600 of yeast culture, the yeast were grown in media 
containing lactate as the major sugar source (referred to as SSlac media).  Under these 
conditions, the yeast are forced to activate the citric acid cycle for energy generation.  
The enzymes involved in the citric acid cycle are contained in the mitochondrial matrix; 
therefore, up-regulation of the citric acid cycle will result in an increase in the amount of 
mitochondria per yeast cell.  Before a mitochondrial isolation was performed, yeast cells 
from the D273-10B strain were streaked onto YEPlac (yeast extract, peptone, 20% Na-  
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Figure II-1.  Structures of the succinimidyl ester of NBD and of εNBD-Lys-tRNAamb. 
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lactate, pH 5.5, and agar) plates, and allowed to sit out at room temperature for 5-7 days.  
During that time stock solutions for the isolation procedure were made.  To make the 
20% Na-lactate (pH 5.5), 235 mL of 85% lactic acid (EM, LX0020-6) was added to 500 
mL H2O, and then solid NaOH pellets were added (while the beaker was cooled with 
ice) until the pH reached 5.5.  The volume was adjusted to 1 L with H2O and autoclaved.  
For 1 L 5X SSlac media, 15 g of yeast extract, 5 g of KH2PO4, 5 g of NH4Cl, 2.5 g of 
NaCl, 2.5 g of CaCl2, 3 g of MgCl2, and 2.5 g of glucose were added to 500 mL of Na-
lactate (pH 5.5) and the volume was adjusted to 1 L with H2O before autoclaving.  To 
make 1X SSlac, the 5X SSlac was diluted 1 to 5 with autoclaved H2O. Three days before 
the prep, a starter culture containing 5 mL 1X SSlac and a swatch of yeast from the 
YEPlac plate was incubated at 30°C overnight with shaking (250 rpm).  The next day, 
100 mL of 1X SSlac, containing the 5 mL of starter culture from the previous night, was 
incubated at 30°C overnight, with shaking, and the OD600 was recorded the next morning 
when the culture was removed from the incubator.   
A volume of the 100 mL starter culture was added to each of two 4 L beakers, 
containing 2 L pf 1X SSlac, such that the OD600 of each 2 L culture was around 0.0625.  
When the cultures were grown with lactate as the sugar source, the doubling time (i.e., 
the time required for the OD600 to increase by a factor of 2) was around 3 hours.  
Therefore, after the 2 L cultures were incubated at 30°C with shaking for 12 hours, the 
OD600 was between 1-2. Once the OD600 was at or above 1.0, the cells were harvested by 
sedimentation at 5,000 RPM, 4°C, for 5 min (Beckman JA-10 rotor), and the media was 
discarded.  The cell pellets were then washed with double-distilled water (ddH2O)  (200 
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mL for a cell pellet from a 2 L culture), centrifuged (at 5,000 RPM, 4°C, 5 min in a 
Beckman JA-14 rotor), and the mass of each wet cell pellet was noted.  The pellets were 
resuspended in 0.1 M Tris-SO4 (pH 9.4)/10 mM DTT at 1 mL buffer/0.3 g cells.   
All resuspensions after this point were done using gentle swirling of the pellet in 
the solution, as opposed to resuspension using glass pipettes, in order to maintain the 
integrity of the mitochondrial membranes. The resuspended pellets were incubated at 
30°C for 15 min with slow shaking (125 RPM), then centrifuged as above.  The pellets 
were then resuspended in 100 mL of 1.2 M sorbitol/20 mM KPO4 (pH 7.4) and 
centrifuged as above. During the sedimentation a 1 mg/mL solution of Zymolyase 20T 
(ICN) was made in the sorbitol/KPO4 buffer.   
The cell pellets were then resuspended in the sorbitol/KPO4 buffer at a volume of 
1 mL/0.15 g cell pellet.  The Zymolyase solution was added to a concentration of 2 mg 
per gram cell pellet, and the cells were incubated at 30°C for 30 minutes, to allow the 
Zymolyase to permeate the yeast cell wall and generate spheroplasts.  After 30 min, the 
cells were centrifuged at 3500 RPM, 5 min, 4°C (Beckman JA-14 rotor), and the 
supernatant was carefully poured away from the loose pellets.  The pellets were gently 
resuspended in 30 mL 1.2 M sorbitol (usually the pellets were mixed into the sorbitol 
with a pipette bulb before swirling to finish the resuspension) and centrifuged for 5 min, 
3500 RPM, 4°C (Beckman JA-14 rotor).  This step was repeated two more times, then 
the pellets were resuspended in ice-cold SEH buffer (250 mM sucrose, 1 mM EDTA, 20 
mM HEPES (pH 7.4), containing 0.5% (w/v) BSA and 1 mM PMSF (as well as 1 µg/mL 
of both aprotinin and leupeptin) at a volume of 2 mL per gram of cells.   
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The resuspension was transferred to a 15 mL Pyrex dounce homogenizer and 
homogenized with 15 strokes using pestle “B”.  The homogenate was then poured into a 
50 mL centrifuge tube, and the dounce was rinsed with an equal volume of SEH buffer.  
This rinse was added to the homogenate, which was then centrifuged 5 min., 3500 RPM, 
4°C (Beckman JA-17 rotor).  The supernatant (containing the mitochondria) was 
transferred to a clean 50 mL centrifuge tube, and the homogenization step was repeated a 
second time with the pellet (which contained unbroken cells and nuclei).  After the 
homogenization step was repeated, the supernatants from the two sedimentation steps 
were combined and then centrifuged at 10,000 RPM, 4°C, for 10 min (Beckman JA-17 
rotor).   
The supernatant was poured off and the pellets (containing the crude 
mitochondrial fraction) were resuspended in 30 mL SEH buffer and centrifuged at 3000 
RPM, 4°C, for 5 min (Beckman JA-17 rotor).  The supernatants were transferred to clean 
50 mL centrifuge tubes and then centrifuged at 10,000 RPM, 4°C, for 10 min (Beckman 
JA-14 rotor).  The supernatant was removed and the last two steps were repeated once 
more with the mitochondrial pellets.  After the second spin at 10,000 RPM, the isolated 
mitochondria were resuspended in 0.5 mL SEH buffer (lacking protease inhibitors) and 
kept on ice.  The yield of mitochondria was calculated by adding 10 µL mitochondria to 
1 mL of 0.6% (w/v) SDS and reading the A280 of the sample (as a blank for the 
spectrophotometer, 10 µL of SEH buffer was added to 1 mL of 0.6% (w/v) SDS).  The 
resulting A280 reading was then put into the following equation to calculate the yield of 
mitochondrial protein:    
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     0.21           =     A280     (1)  
            10 mg/mL         C mg/mL  
 
where C = the concentration of the prepped mitochondria.  By multiplying the 
concentration, C, by the volume in mL of the prep the total mitochondrial protein in mg 
could be determined.  The mitochondria were split into 0.5 mg aliquots and frozen with 
liquid nitrogen, then stored at –80°C.  The frozen mitochondria would generally be 
stable for 2-3 months.   
  
Site-Directed Mutagenesis 
DNA primers were synthesized commercially and ordered from either Integrated 
DNA Technologies (IDT) or Sigma-Genosys.  Primers were resuspended in ddH2O to a 
stock concentration of 50 pmol/µL.  A working stock of each primer was then made to a 
concentration of 125 ng/µL.  A typical PCR reaction contained the following: 1X Pfu 
buffer (Stratagene), 200 µM of each dNTP, 2 mM MgCl2, 2.5 ng each of the forward and 
reverse primers, 50 ng template DNA, and water to adjust the volume to 50 µL, then 0.5 
µL of 2.5 U/µL Pfu polymerase (also from Stratagene) was added.  The thermal cycler 
conditions are as follows:  initial heating to 95°C for 30 sec, then 20 cycles of denaturing 
at 95°C for 30 sec, annealing at 55°C for 1 min., and elongation at 68°C for 7 min, 
followed by cooling the reaction to 4°C.   
After the PCR reaction was finished, 2 µL of 10 U/µL DpnI (Promega) was 
added to each tube, and the reactions were incubated at 37°C for 1-2 hours.  The treated 
reaction (1 µL) was added to 50 µL competent E. coli cells (MC1061 or Top10 cells 
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(Invitrogen)) and allowed to incubate on ice for 15 minutes.  The cells were heat-
shocked at 42°C for 60 seconds, then cooled again on ice for 2 min.  SOC or LB media 
(450 µL) were added to the cells, and the reaction was incubated at 37°C with shaking 
(250 rpm) for 1 hour.  Cells (100 µL) were then spread onto LB plates containing 50 – 
100 µg/mL ampicillin, and the plates were incubated overnight at 37°C before being 
stored at 4°C.  Colonies were picked, and plasmid DNA was isolated using a QiaSpin 
miniprep kit.  Aliquots of the plasmid DNA were sent to the DNA Technologies Lab 
(College of Veterinary Medicine, Texas A&M) for sequencing.  Typically, the primer 
1166-HC was used as the sequencing primer.  The rest of the purified plasmid DNA was 
stored at –20°C.   
Table II-1 lists all of the primers used to make the mutations necessary for this 
thesis.  The naming of the primers follows that adopted by the Johnson lab, where each 
primer is assigned the next number in the sequence, followed by the initials of the person 
who ordered the oligo. 
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Table II-1.  Primers for site-directed mutagenesis of Su9-DHFR 
constructs 
    
Name Sequence Complement Mutation 
227-HC GCTCAGGTCAGCTAGCGCACCAT
CCAGACTGGC 
228-HC K33 -> TAG 
228-HC GCCAGTCTGGATGGTGCGCTAGC
TGACCTGAGC 
227-HC K33 -> TAG 
229-HC CCTCTTCAGTGGAAGGTTAGCAG
AACCTGGTGATTATGGG 
230-HC K119 -> TAG 
230-HC CCCATAATCACCAGGTTCTGCTA
ACCTTCCACTGAAGAGG 
229-HC K119 -> TAG 
231-HC GTTCTCAGTAGAGAGCTCTAGGA
ACCACCACCAGG 
232-HC K153 -> TAG 
232-HC CCTCGTGGTGGTTCCTAGAGCTCT
CTACTGAGAAC 
231-HC K153 -> TAG 
233-HC GATTTGGGGAAATATTAGCTTCT
CCCAGAATACCCAGGC 
234-HC K230 -> TAG 
234-HC GCCTGGGTATTCTGGGAGAAGCT
AATATTTCCCCAAATC 
233-HC K230 -> TAG 
237-HC GCCACCACCCGCCAGTAGTTCCA
GAAGCGCGCCTAC 
238-HC A61 -> TAG 
238-HC GTAGGCGCGTTCTGGAACTACTG
CGCGGTGGTGGC 
237-HC A61 -> TAG 
239-HC CTCAAGCGCACCCAGTAAGAGCT
CCATCGTCAAC 
240-HC M50 -> TAG 
240-HC GTTGACGATGGAGCTCTACTGGG
TTGAACTGCATC 
239-HC M50 -> TAG 
241-HC GACGGCATCATGGTTTAGCCGTT
GAACTGCATC 
242-HC R75 -> TAG 
242-HC GATGCAGTTCAACGGCTAAACCA
TGATGCCGTC 
241-HC R75 -> TAG 
255-HC CGCGCCTACTCTTCCTAGGGCAT
CATGGTTCGACC 
256-HC D70 -> TAG 
256-HC GGTCGAACCATGATGCCCTAGGA
AGAGTAGGCGCG 
255-HC D70 -> TAG 
285-HC CCGACGGCATCTAGGTCCGACCA
TTGAACTGC 
286-HC M73 -> TAG 
286-HC GCAGTTCAATGGTCGGACCTAGA
TGCGTCGG 
285-HC M73 -> TAG 
621-HC GCCTCCACTCGTGTCCTCTAGTCT
CGCCTGGCCTCC 
622-HC A8 -> TAG 
622-HC GGAGGCCAGGCGAGACTAGAGG
ACACGAGTGGAGGC 
621-HC A8 -> TAG 
689-HC GCCTCCACTCGTGTCCTCTAGTCT
CGCCTGGCCTCCCAG 
690-HC A8 -> TAG 
 32
Table II-1, continued   
    
Name Sequence Complement Mutation 
690-HC CTGGGAGGCCAGGCGAGACTAG
AGGACACGAGTGGAGGC 
689-HC A8 -> TAG 
691-HC ATGGCTGCTTCCGCCTAGGTTGC
CCGCCCTGCT 
692-HC K20 -> TAG 
692-HC AGCAGGGCGGGCAACCTAGGCG
GAAGCAGCCAT 
691-HC K20 -> TAG 
693-HC AAGGTTGCCCGCCCTTAGGTCCG
CGTTGCTCAGGTC 
694-HC A25 -> TAG 
694-HC GACGTGAGCAACGCGGACCTAAG
GGCGGGCAACCTT 
693-HC A25 -> TAG 
727-HC GGTTCGACCATTGAACGCCATCG
TCGCGGTCTCCC 
728-HC C79 -> ALA 
728-HC GGGACACGGCGACGATGGCGTTC
AATGGTCGAACC 
727-HC C79 -> ALA 
749-HC CCACTCGTCTCCTCTGTTCTCGCC
TGGCCTCCCAGATGG 
750-HC A8 -> CYS 
750-HC GCATCTGGGAGGCCAGGCGAGA
ACAGAGGAGACGAGTGG 
749-HC A8 -> CYS 
751-HC CTCGCCTGGCCTCCCAGTGTGCT
GCTTCCGCC 
752-HC M15 -> CYS 
752-HC GGCGGAAGCACCACACTGGGAG
GCCAGGCGAG 
751-HC M15 -> CYS 
753-HC GTTGCCCGCCCTTGTGTCCGCGTT
GCTCAG 
754-HC A25 -> CYS 
754-HC CTGAGCAACGCGGACACAAGGG
CGGGCAAC 
753-HC A25 -> CYS 
755-HC GCTCAGGTCAGCAAGCGCTGTAT
CCAGACTGGCTCCC 
756-HC T35 -> CYS 
756-HC GGGAGCCAGTCTGGATACAGCGC
TTGCTGACCTGAGC 
755-HC T35 -> CYS 
757-HC CCCTCAAGCGCACCCAGTGTACC
TCCATCGTCAACGCC 
758-HC M50 -> CYS 
758-HC GGCGTTGACGATGGAGGTACACT
GGGTGCGCTTGAGGG 
757-HC M50 -> CYS 
759-HC GCCACCACCCGCTGTGCTTTCCA
GAAGCGCGC 
760-HC Q60 -> CYS 
760-HC GCGCGCTTCTGGAAAGCATAGCG
GGTGGTGGC 
759-HC Q60 -> CYS 
761-HC GGCTTTCCAGAAGCGCTGTTACT
CTTCCGACGGCATC 
762-HC A66 -> CYS 
762-HC GATGCCGTCGGAAGAGTAACAGC
CCTTCTGGAAAGCC 
761-HC A66 -> CYS 
763-HC CGCGCCTACTCTTCCTGTGGCATC
ATGGTTCGTCC 
764-HC D70 -> CYS 
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Table II-1, continued   
    
Name Sequence Complement Mutation 
    764-HC GGTCGAACCATGATGCCACAGGA
AGAGTAGGCGCG 
763-HC D70 -> CYS 
765-HC GAAGAAAGACAGATCTGCCCACC
ACCACCACCACCACAAGC 
766-HC C263 -> ALA 
766-HC GCTTGTGGTGGTGGTGGTGGTGG
GCAGATCTGTCTTTGTTG 
765-HC C263 -> ALA 
767-HC GCCTCCACTCGTGTCTAGGCCTCT
CGCCTGGCCTCC 
768-HC L7 -> TAG 
768-HC GGAGGCCAGGCGAGAGGCCTAG
ACACGAGTGGAGGC 
767-HC L7 -> TAG 
769-HC CGCCTGGCCTCCCAGTAGGCTGC
TTCCGCCAAG 
770-HC M15 -> TAG 
770-HC CTTGGCGGAAGAAGACTACTGGG
AGGCCAGGCG 
769-HC M15 -> TAG 
771-HC GGTTGCCCGCCCTTAGGTCCGCG
TTGCTCAGGTC 
772-HC A25 -> TAG 
772-HC GACCTGAGCAACGCGGACCTAAG
GGCGGGCAACC 
771-HC A25 -> TAG 
773-HC CAGACCCTCAAGCGCACCCAGTA
GACCTCCATCGTCAACGCC 
774-HC M50 -> TAG 
774-HC GGCGTTGACGATGGAGGTCTACT
GGGTGCGCTTGAGGGTCTG 
773-HC M50 -> TAG 
775-HC GCCTCCACTCGTGTCTGCGCCTCT
CGCCTGGCCTCC 
776-HC L7 -> CYS 
776-HC GGAGGCCAGGCGAGAGGCGCAG
ACACGAGTGGAGGC 
775-HC L7 -> CYS 
777-HC GTTGCTCAGGTCAGCTGCCGCAC
CATCCAGACTGGC 
778-HC K33 -> CYS 
778-HC GCCAGTCTGGATGGTGCGGCAGC
TGACCTGAGCAAC 
777-HC K33 -> CYS 
779-HC CAGACCCTCAAGCGCACCCAGTG
CACCTCCATCGTCAACGCC 
780-HC M50 -> CYS 
780-HC GGCGTTGACGATGGAGGTGCACT
GGGTGCGCTTGAGGGTCTG 
779-HC M50 -> CYS 
837-JS CAGATGGCTGCTTCCGCCTGTGTT
GCCCGCCCTGCTGTCCGC 
838-JS S20 -> CYS 
838-JS GCGGACAGCAGGGCGGGCAACA
CAGGCGGAAGCAGCCATCTG 
837-JS S20 -> CYS 
839-JS CAGATGGCTGCTTCCGCCTAGGT
TGCCCGCCCTGCTGTCCGC 
840-JS S20 -> TAG 
840-JS GCGGACAGCAGGGCGGGCAACC
TAGGCGGAAGCAGCCATCTG 
839-JS S20 -> TAG 
841-JS CGCACCATCCAGACTGGCTGTCC
CCTCCAGACCCTCAAGCGC 
842-JS K40 -> CYS 
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Table II-1,  continued   
    
Name Sequence Complement Mutation 
842-JS GCGCTTGAGGGTCTGGAGGGGAC
AGCCAGTCTGGATGGTGCG 
841-JS K40 -> CYS 
843-JS CGCACCATGCAGACTGGCTAGCC
CCTCCAGACCCTCAAGCGC 
844-JS K40 -> TAG 
844-JS GCGCTTGAGGGTCTGGAGGGGCT
AGCCAGTCTGGATGGTGCG 
843-JS K40 -> TAG 
 
 
 
 
Plasmids 
 The plasmid pGEM 4z Su9-DHFR, containing the ORF for Su9-DHFR under 
control of the SP6 promoter, was a gift from Dr. Rob Jensen (Johns Hopkins University, 
Baltimore, Maryland).  Site-directed mutagenesis of this plasmid was performed to 
engineer amber codons (TAG) at specific positions in the ORF.  The constructs made 
using this technique were named Su9-DHFR TAG-X, with X indicating the number of 
the amino acid position containing the mutation.  The positions of each of the amber 
mutants of Su9-DHFR are shown in Figure II-2.   
Site-directed mutagenesis was also performed to engineer cysteine residues at 
specific positions in the Su9-DHFR ORF.  The cysteine mutants were referred to as Su9-
DHFR Cys-X, with the X indicating the position of the cysteine mutation, as with the 
TAG mutants.  The positions of the Cys mutants of the Su9-DHFR constructs are also 
shown in Figure II-2.  The native cysteine residue is located at position 79 in the 
construct, and was not altered. 
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PCR Generation of Full-length Su9-DHFR 
A 5’-forward primer was synthesized that included the SP6 promoter sequence, 
the Kozak sequence, and the first 24 bases of the Su9-DHFR ORF (encoding the first 8 
amino acids).  This primer could be used for any Su9-DHFR construct to generate 
ssDNA for in vitro transcription reactions.  3’-primers were designed to generate full-
length DNA products for each Su9-DHFR construct.  These primers were ordered from 
IDT or Sigma-Genosys, and resuspended in ddH2O to a concentration of 50 pmol/µL. 
The primers are listed below (Table II-2).  A typical PCR reaction contained 1X 
ExTaq polymerase buffer (Takara), 200 µM each dNTP, 100 pmol each of forward 
and reverse primers, 100 ng template DNA, and ddH2O to a total volume of 100µL.  
ExTaq DNA polymerase (0.5 µL,Takara) was added to each reaction, and a 
“touchdown” PCR reaction was performed.  The PCR reaction conditions are as follows:  
initial heating at 94°C for 5 min, followed by 10 cycles of denaturation at 94°C for 30 
sec., annealing at 70°C for 30 sec, and elongation at 72°C for 1 min, followed by 20 
cycles of denaturation at 94°C for 30 sec., annealing at 57°C for 30 sec., and elongation 
at 72°C for 1 min.  The reactions were held at 72°C for 7 min before being cooled to 
4°C.  At the end of the PCR reaction the PCR products were isolated using the QiaQuick 
PCR Purification Kit (Qiagen), and resuspended in 45 µL ddH2O.  For verification that 
the amplification reactions were successful, 5 µL of each sample were run on a 1% 
agarose gel. The other 40 µL of the PCR reaction was stored at –20°C.   
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Table II-2.  Primers for PCR-generated DNA fragments 
Name Sequence Template Purpose
1058-HC GTACATATTGTCGTTAGAACGCGGC
pGEM Su9-
DHFR upstream primer
1251-HC GCATAGCTTTAGGAGGGGAGC
pGEM Su9-
DHFR FL Su9-DHFR
1307-HC
ATTTAGGTGACACTATAGAAACCACC
ATGGCCTCCACTACTCGTGTCCTC
all Su9-DHFR 
constructs upstream primer
1362-HC GGATCTATGAACAGGAGTCCAAGC
pQE60 Su9-
DHFR-Cys-
FL Su9-DHFR-Cys-
His6
 
 
 
In vitro Transcription 
 A 100 µL transcription reaction contained the following:  5 µL PCR-amplified 
DNA (see above), 80 mM HEPES (pH 7.5), 16 mM MgCl2, 2 mM spermidine, 10 mM 
DTT, 3 mM each ATP, CTP, and UTP, 1.5 mM GTP, 500 µM diguanosine triphosphate 
[G(5’)ppp(5’)G] (Amersham), 0.5 units  pyrophosphatase, 50 units RNasin 
ribonuclease inhibitor (Promega), and 100 units of SP6 polymerase.  The reactions were 
incubated for 90 min at 37°C, then an additional 3.2 mM GTP was added and the 
reaction was incubated at 37°C for another 30 min.  The mRNA was typically purified 
using one of two methods:  standard ethanol precipitation or isolation via the RNeasy 
Kit (Qiagen).  Regardless of the isolation method used, the samples were resuspended in 
85 µL TE buffer (10 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 7.5)), and 5 µL were run 
on an 1.6% agarose gel for verification that the transcription was successful; the other 80 
µL were stored at –80°C.    
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In vitro Translation 
 The mRNAs made in the in vitro transcription reactions were translated in a 
wheat germ cell-free translation system.  A typical 25 µL reaction contained 20 mM 
HEPES (pH 7.5), 3 mM Mg(OAc)2, 70 - 90 mM KOAc (pH 7.5), 1.6 mM DTT, 200 µM 
spermidine, 8 µM SAM (S-adenosylmethionine), 1X protease inhibitors, 2 µL EGS 
(energy-generating system with 120 mM creative phosphate, 0.12 units/µL creatine 
phosphokinase, and 375 µM each of the 20 amino acids), 4 µL wheat germ extract 
(purified according to Erickson and Blobel (year?)), 10 units RNasin, 15 pmol 
[14C]Lys-tRNAamb, and 2 µL mRNA. For translations which would be examined by 
SDS-PAGE, EGS-M was used (EGS lacking methionine), and 0.2 – 1.0 µCi/µL 
[35S]methionine (Perkin-Elmer) was added as well.  Before addition of the mRNA, 
tRNA, and, if needed, [35S]methionine, the reaction was incubated for 5 min at 26°C, to 
allow for unlabeled translation of any endogenous mRNAs.  The reaction was placed 
back on ice, then the tRNA and mRNA were added, and the reaction was incubated at 
26°C for another 35 min, and then returned to ice.  When the translations were examined 
using SDS-PAGE, 2 µL of the translation reaction was added to 20 µL 1X SDS loading 
buffer (with DTT added) and heated to 95°C for 5 min.  The samples were then loaded 
onto a 12.5% SDS gel and run at 100 V for 1 hour.       
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Import into Yeast Mitochondria 
An aliquot of frozen mitochondria (0.5 – 1.0 mg) was thawed on ice 
(approximately 30 min.).  The thawed mitochondria were resuspended in sucrose import 
buffer (SIB), containing 250 mM sucrose, 80 mM KCl, 5 mM MgCl2, 2 mM KPO4 (pH 
7.5), 20 mM HEPES (pH 7.5), and 0.3% (w/v) BSA (Sigma A-0281), to a final 
concentration of 1 mg/mL.  The resuspended mitochondria were then pelleted in a 
refrigerated centrifuge at 9000 g for 5 min at 4°C.  After the supernatant was removed by 
aspiration, the mitochondria were resuspended in 0.2 mL SIB the amount of 
mitochondrial protein was determined from the A280 as above.  Unless otherwise noted, 
small-scale import reactions (i.e., those used for SDS-PAGE analysis) were typically 
prepared using 5 µL of the translation incubation and 50 µL of 0.25 mg/mL 
mitochondria, along with either 2 mM each of malate and pyruvate or 2 mM each of 
ATP and NADH, added as ATP-regenerating substrates.  The reactions were incubated 
at 26°C for 15 min, then placed on ice to stop the import reaction.  Unless import 
reactions were followed with another treatment (i.e., protease digestion), the 
mitochondria were then centrifuged at 20,000 g and 4°C for 5 min, after which 
mitochondrial pellets were resuspended in SDS sample buffer (with DTT added).  
Import reactions for fluorescence experiments were generally much larger, and 
the reaction conditions differed slightly from the smaller import reactions.  Typically, 
100 µL of 0.5 mg/mL mitochondria (in the presence of 2 mM malate and pyruvate) were 
added to 1000 µL of translation incubation, and 140 µL of 2 M sucrose was added to 
keep the mitochondria osmotically stable.   
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Occasionally, imports were performed in the absence of a ∆Ψ, which would 
prevent the precursor protein from crossing the IM.  Under these conditions, 50 µM 
carbonyl cyanide 3-chlorophenylhydrazone (CCCP, Sigma C-2759) was added to the 
import reactions to dissipate the membrane potential across the IM before the import 
reactions were completed as above. 
 
Generation of Mitochondrial Import Intermediates 
 To generate an import intermediate across both mitochondrial membranes, 
methotrexate (MTX; Sigma M-9929), a substrate analog for DHFR, was added to the 
samples after the translation reaction.  Addition of methotrexate to Su9-DHFR causes 
the DHFR domain to fold tightly, preventing it from being pulled across the 
mitochondrial membranes.  In this way, an import intermediate can be created in which 
the Su9 presequence crosses both the OM and IM and is bound in the matrix by 
mtHsp70, while the DHFR polypeptide remains on the cytosolic side of the OM.  A 10 
mM MTX stock was made by diluting 4.5 mg of MTX into 50 µL of 3 N NaOH.  The 
volume was then brought up to 1 mL with SIB, and the stock was stored in at –20°C.  
For each experiment, the 10 mM stock was thawed and diluted 1:100 in SIB to make a 
100 µM MTX solution.  To generate Su9-DHFR•MTX intermediates, MTX was added 
to a final concentration of 2 µM at the end of a translation reaction and the samples were 
allowed to incubate on ice for 5 min.  Mitochondria were then added to the reactions as 
described above, except that a concentration of 2 µM MTX was kept in the import 
reactions, to avoid diluting the MTX and losing the import intermediates. 
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Preparation of Fluorescent Samples 
 To perform collisional quenching experiments, mitochondrial import 
intermediates were generated using the conditions described above, except that each 
experiment required two reactions, one in the presence of εNBD-[14C]Lys-tRNAamb 
(termed the Sample) and the other in the presence of unmodified [14C]Lys-tRNAamb (the 
Blank).  After completion of the import reaction, the mitochondria were pelleted for 5 
min at 10,000g, in a refrigerated centrifuge, and the supernatant was then aspirated.  The 
mitochondria were resuspended in 1 mL of Buffer A/K+/E (similar to the SLM Buffer, 
except for the presence of 250 mM KOAc (pH 7.5) and 60 mM EDTA) and allowed to 
incubate on ice for 15 min.  The mitochondria were then pelleted again for 5 min at 
10,000g and 4°C, the supernatant was aspirated, and the sample tubes were then pulsed 
again (at 10,000g, about 30 sec) to ensure that all liquid in the tubes had sedimented to 
the bottom.  This liquid was also removed, and the mitochondria were resuspended in 
350 µL of SLM Buffer.  When the samples being analyzed were import intermediates, 2 
µM MTX was kept in the buffers at all times. 
 
Fluorescence Spectroscopy 
All fluorescence experiments were performed in an SLM Aminco 8100 photon-
counting specrofluorimeter using 4 mm x 4 mm square quartz microcell cuvettes 
(Starna) and a temperature of 4°C.  The cuvette chamber was continuously flushed with 
N2 to prevent condensation of water on the cuvettes.  Each cuvette had a small magnetic 
“stir flea” at the bottom to mix samples after each addition as described (Dell et al, 1990) 
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and the cuvettes were always re-equilibrated to 4°C before any readings were taken.  To 
eliminate light scattering and background signal from the observed NBD fluorescence 
intensity of the Sample, both the Sample and Blank intensities were measured using 
excitation and emission wavelengths of 468 nm and 485 nm, respectively, with a 4 nm 
bandpass.  The Sample and Blank were equalized with respect to the amount of 
background and scattering signal by diluting the sample with the higher signal until both 
the Sample and Blank had the same emission intensity at 485 nm.  The emission was 
then scanned at 1 nm intervals between 490 and 600 nm.  Emission spectra were taken of 
both the Sample, containing NBD, and the Blank, lacking NBD, and the spectrum of the 
Blank was subtracted from the Sample spectrum to obtain the net NBD emission 
spectrum. 
 
Collisional Quenching of NBD with Iodide Ions 
Aliquots (150 uL) of the Sample, containing NBD, and of the Blank, lacking 
NBD, were distributed to two microcells each, termed S1 and S2 and B1 and B2.  The 
fluorescence intensities of all cuvettes were read using excitation and emission 
wavelengths of 468 nm (bandpass = 4 nm) and 530 nm (bandpass = 4 nm), respectively, 
and the initial net NBD fluorescence (F0) was calculated by subtracting the Blank signal 
from the Sample signal (B1 from S1, and B2 from S2).  Then iodide ions (5 µL of 0.8 M 
KI) were added to S1 and B1, and the net fluorescence intensity was measured again.  
As a control for any effects of increasing ionic strength on the sample NBD intensities, 5 
µL of 0.8 M KCl were added to S2 and B2 and the net fluorescence intensity was 
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determined.  The KCl and KI additions were repeated two more times, so that emission 
intensities (F) were measured at KI or KCl concentrations of 0, 25, 50 or 72 mM.  
Corrections were made to each intensity reading to account for dilution effects.  
Alamethicin (ALA) was then added each cuvette as described above, and the 
fluorescence intensities were measured again.   
For steady-state collisional quenching of fluorescence, the data were analyzed 
according to the Stern-Volmer law: 
(F0/F) – 1 = Ksv [Q]   (2) 
where Ksv is the Stern-Volmer quenching constant and Q is the concentration of 
quencher.  There was minimal decrease in NBD emission intensity at increasing KCl 
concentrations, revealing that NBD fluorescence and sample constituents were 
minimally affected by increasing ionic strength.  The iodide Ksv was then determined by 
first using non-linear regression to ascertain the slope of the “best-fit” straight line 
through the KI data.  This analysis was repeated for the KCl data to determine the 
chloride Ksv.  The net iodide Ksv was then determined by subtracting the best-fit KCl Ksv 
from the best fit KI Ksv (Crowley et al, 1993).  A typical experiment is shown in Figure 
II-3.  
 
Biochemical Analysis of Fluorescent Samples 
 At the conclusion of each fluorescence experiment, the volume from each cuvette 
was collected and the radioactivity (hence, NBD probe) content was determined using a 
liquid scintillation counter.  Typically, sample volume was adjusted to a final volume of 
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400 µL and put into a 5 mL insert vial, 4 mL of Trition-based scintillation cocktail was 
added, and the 14C cpm (counts per minute) were measured. Alternatively, half of the 
volume (~80 µL) was added to an insert vial to determine the total Triton 14C counts, 
while the mitochondria in the other half of the sample were sedimented for 10 min, 
20,000g and 4°C in a microfuge.  The supernatant was removed, put into an insert vial 
and counted as above, while the mitochondrial pellet was resuspended in 400 µL of 2%  
(w/v) SDS before being transferred to an insert vial and determining the 14C cpm as 
above.  By splitting the volume of the fluorescent samples, it was possible to determine 
the total cpm of the sample as well as the cpm that remained associated with the 
mitochondria.  The ratio of the net NBD emission intensity in pulses per second (pps) to 
the number of NBD probes in the sample in cpm was determined for each fluorescence 
experiment.  Any change in the pps/cpm ratio for a particular construct would indicate 
that the environments of some or all of the NBD dyes had changed. 
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Figure II-3.  Stern-Volmer plot for collisional quenching of NBD-Su9-
DHFR by KI.  After import of NBD-Su9-DHFR presequences, in the 
presence of absence of MTX, the Sample (containing NBD) and the Blank 
(lacking NBD) are titrated with both KI and KCl.  The titration data for KI 
is shown in blue, and the titration data for KCl is shown in green.  The net 
F0/F, obtained by subtraction of the KCl data from the KI data, is shown in 
red.  The slope of each regression line (Stern-Volmer quenching constant, 
or Ksv) is shown in the identical color. 
y = 7.3x
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Protease Digestions 
 After completion of import reactions, the samples were split into two aliquots 
(one for protease digestion, one for a negative control).  To the aliquot that would 
receive the protease treatment, 1 mg/mL proteinase K (Sigma P-2308) was added to a 
concentration of either 50 µg/mL (“light” protease digestion) or 100 µg/mL (“typical” 
protease digestion).  Occasionally, 50 µg/mL trypsin (Sigma, T-8642) was added to the 
import reactions instead.  The samples were allowed to incubate on ice for 15 min, then 
the reactions were quenched with either 1 mM PMSF (Sigma, P-7626) for the proteinase 
K reactions or 100 µg of trypsin inhibitor (Sigma, T-9003).  The reactions were 
centrifuged at 20,000 g for 5 min at 4°C in a microcentrifuge.  The supernatants were 
aspirated and the mitochondrial pellets resuspended in SDS Sample Buffer (+DTT) 
before being analyzed by SDS-PAGE.   
 
Alamethicin Treatments 
 To perforate the mitochondrial IM, the pore-forming antibiotic alamethicin 
(ALA; Sigma A-4665) was added to a final concentration of 3.5 – 8 ug/mL, and the 
samples were allowed to incubate at room temperature for 10 min.   
 
Propidium Iodide Assay of Mitochondrial IM Integrity 
 In order to assay the integrity of the IM of the isolated mitochondria, advantage 
was taken of the fact that mitochondria possess their own genomic DNA, located in the 
mitochondrial matrix.   By adding a DNA-intercalating fluorescent dye to the 
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mitochondria, the integrity of the IM could be evaluated by comparing the fluorescence 
intensity of the dye before and after the addition of alamethicin, an antibiotic that forms 
holes in the mitochondrial IM.  To perform this experiment, mitochondria were washed 
in SIB and centrifuged as above, but were then resuspended in PI Buffer (20 mM 
HEPES (pH 7.4), 3 mM Mg(OAc)2, 70 mM KOAc (pH 7.4), 250 mM sucrose).  After an 
A280 reading of the mitochondria was taken as described previously to calculate the 
amount of mitochondrial protein, the mitochondria were resuspended to a concentration 
of 0.25 mg/mL and 250 µL were then added to a quartz microcell (250 µL PI Buffer was 
added to another microcell for blank subtraction).   A working solution of 100 µM 
propidium iodide (Molecular Probes, P-3566) was made by diluting the 1.5 mM stock 
into H2O.   The fluorescence intensities of the sample and blank were read at an 
excitation wavelength of 535 nm and an emission wavelength of 617 nm, with the 
temperature of the fluorimeter turret kept at 4°C.  Propidium iodide (5 µL of 100 µM) 
was added to both microcells and the intensities were read again.  ALA (5 µL of 5 
mg/mL) was then added to both microcells and the samples were allowed to incubate at 
room temperature for 10 min.  After the microcells were returned to the fluorimeter 
turret and allowed to equilibrate to 4°C, the fluorescence intensities were read again.  
The readings were corrected to adjust for dilution, and the fluorescence intensities before 
and after addition of ALA were then compared by reporting the –ALA intensity of a 
sample as a percentage of it’s +ALA reading.  This percentage was then taken to be 
equal to the fraction of mitochondria whose IM was no longer intact and sealed.   
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JC-1 Assay of Mitochondrial Membrane Potential 
 The membrane potential of the mitochondrial inner membrane was monitored 
using the potentiometric dye JC-1.  JC-1 (Molecular Probles, T-3168) partitions into the 
mitochondrial IM and exists as a monomer when the potential difference across the 
membrane is low.  But in the presence of higher potentials, JC-1 will form “J-
aggregates”.  The fluorescence excitation and emission maxima are distinctly different 
under these two conditions, making it possible to monitor the potential of the 
mitochondria by comparing the fluorescence intensities of the monomer peak and the J-
aggregates peak.  Typically, mitochondria were thawed and washed as described above, 
then resuspended to a concentration of 12.5 ng/mL in SLM Buffer (20 mM HEPES (pH 
7.5), 3 mM Mg(OAc)2, 25 mM KOAc (pH 7.5), 250 mM sucrose, 2 mM malate, 2 mM 
pyruvate).  The JC-1 dye was resuspended in DMSO to a stock concentration of 1.5 mM 
and was kept at –20° C.  For each experiment, the stock was diluted to 150 nM in 
DMSO.  To perform the fluorescence experiments, bandpass on the SLM fluorimeter 
was set to 1 nm, and the excitation and emission monochromators were set to 575 nm 
and 590 nm, respectively.  For a time trace, 3.5 µL of 150 nM JC-1 were added to 250 
µL mitochondria in a quartz microcell, and the fluorescence intensity monitored over 
1200 sec.  About 120 sec before the end of the scan 50 mM CCCP was added to 
depolarize the mitochondria inner membrane, to verify that the fluorescence intensity 
being monitored was due to the mitochondrial membrane potential.  For emission scans, 
the excitation monochromator was set to 485 nm and the emission monochromator was 
scanned from 500 – 600 nm.  The intensities of the monomer peak (540 nm) and 
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aggregate peak (590 nm) were then compared to gauge the extent of membrane 
polarization. 
 
Chemical Crosslinking 
 Chemical crosslinking reactions were performed using mitochondrial import 
intermediates to analyze the positions of the intermediates relative to the import 
machinery.  The reagent BMH (Pierce, 22330) is a homobifunctional cysteine-cysteine 
crosslinker with a spacer arm of 16 Å that can be used in conjunction with the Su9-
DHFR Cys mutants.  Import intermediates were made using the Su9-DHFR Cys 
constructs and MTX, as described previously.  After the import reaction, BMH was 
added to a final concentration of 100 µM and the samples were incubated at room 
temperature for 35 min (control reactions were performed in the presence of DMSO, the 
BMH solvent).  The samples were then quenched by the addition of 70 mM Tris-HCl 
(pH 7.5), and 70 mM DTT, and incubation at room temperature for another 15 min.  The 
mitochondria were then sedimented and the samples prepared for SDS-PAGE as 
described above. 
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CHAPTER III 
RESULTS 
 
 
Necessity for Developing a Fluorescence-based System 
 The field of mitochondrial protein import has made many advances in the past 
two decades, much of which is summarized in Chapter I.  Previously, it had been 
believed that proteins destined for the mitochondria spontaneously crossed the outer and 
inner membranes (OM and IM), without the aid of transport systems.  However, over the 
past twenty years more than 25 proteins, in more than six separate translocons, have 
been discovered occupying both the OM and IM, as well as residing in the IMS and 
matrix, to aid protein translocation across the mitochondrial membranes.  Most of the 
Tom and Tim proteins were discovered using either yeast genetic techniques or in vitro 
binding studies, or by examining open reading frames (ORFs) from the yeast genome 
database.  However, in order to understand more fully the operation of the mitochondrial 
protein import pathways, it would be useful to examine these pathways from the 
perspective of a translocating polypeptide.  By site-specifically positioning a fluorescent 
probe into a matrix-targeted protein it becomes possible to take advantage of the 
properties of the probe, such as accessibility to an externally added quencher or changes 
in the fluorescent lifetime of the probe in response to the probe’s environment. 
Site-specific fluorescence and photocrosslinking experiments of the kind 
proposed for this project have been used to examine protein translocation across, and 
integration into, the endoplasmic reticulum (ER) membrane.  Briefly, the 
environmentally sensitive fluorophore NBD was site-specifically incorporated into the 
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secretory protein preprolactin (pPL) by adding NBD-labeled lysine tRNAs to the 
translation reaction (Crowley et al, 1994).  In the presence of isolated ER microsomes, 
the resulting NBD-labeled ribosome-nascent chains (RNCs) formed translocation 
intermediates at the ER translocon, with the position of the NBD probe along the 
translocation channel dictated by the location of the probe in the nascent chain and the 
length of the truncated mRNA used in the translation reaction.  By monitoring the 
fluorescent lifetime of the NBD probe under these experimental conditions, the authors 
were able to determine that the nascent chain moves through an aqueous tunnel as it 
crosses the ER membrane (Crowley et al, 1994).   
Subsequent work by Hamman et al, (1997) employed collisional quenching of 
the fluorescent-labeled, membrane-bound RNCs with externally added (thus, 
cystoplasmic) iodide ions.  The authors found that as the NBD probe moved through the 
ribosomal tunnel and the translocon it was inaccessible to these cytoplasmic iodide ions, 
indicating that the ribosome forms a tight seal with the translocon on the cytosolic side 
of the membrane, sealing off the nascent chain from the cytoplasm and preventing ion 
leakage from the ER lumen through the translocon during translocation.  Immediately 
after targeting, the nascent chain was also inaccessible to quencher in the ER lumen 
(Crowley et al, 1999) because BiP closed the lumenal end of the aqueous pore either 
directly or indirectly (Hamman et al, 1998).  However, when the length of the nascent 
chain was increased to longer than 70 residues, the fluorescent probes located inside the 
ribosome become accessible to collisional quenching from the lumenal side of the ER 
membrane (Crowley et al, 1994; Hamman et al, 1997).  Indeed, quenchers as large as 
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NAD+ were able to quench the NBD probes located in the ribosome tunnel of the 
membrane-bound RNCs, which suggested that the pore of an active translocon is as 
large as 60 Å in diameter (Hamman et al, 1997). 
These data then raised the question of what protein or complex maintains the 
permeability barrier of the translocon in the absence of a translating ribosome.  
Collisional quenching experiments on ER membranes showed that a ribosome-free 
translocon has a pore size of 10-15 Å, much smaller than that of an active translocon, 
and that the luminal protein BiP maintains the permeability barrier from the luminal side 
of the translocon (Hamman et al, 1997, 1998). 
 Fluorescence spectroscopy proved supremely useful in studying ER translocation 
because this approach allowed the translocation pathway to be studied from the 
perspective of the nascent chain in a functional system.  Many of the questions answered 
in the ER system are pertinent to the field of mitochondrial protein import:  Does a 
translocating preprotein cross the IM via an aqueous channel?  How is the IM membrane 
potential maintained during translocation through the TIM23 complex?  Is a 
translocating preprotein ever exposed to the IMS during translocation through the TOM 
and TIM23 complexes?  The goal of this project was to apply spectroscopic techniques 
to study translocation through the mitochondrial import system in order to address some 
of the questions that could not be answered using conventional cell biology techniques.  
These techniques included site-specifically labeling a model matrix protein with a 
fluorescent dye, generating import intermediates with the labeled matrix protein, and 
analyzing the fluorescent properties of the dye in the resultant complexes.   
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Experimental Design 
The model matrix protein Su9(1-69)-DHFR has been used in previous 
mitochondrial import experiments to generate translocation intermediates.  It consists of 
the matrix-targeted presequence of subunit 9 of the F1-Fo ATPase, fused to 
dihydrofolate reductase (DHFR) as the passenger protein.  The Su9 presequence is 
sufficient to direct the protein to isolated mitochondrial (Hurt et al, 1994), and, in the 
presence of the folate analog methotrexate (MTX), the DHFR moiety will fold into a 
tight complex (Eilers and Schatz, 1986).  In the presence of mitochondria and an ATP-
regenerating system the polypeptide will be imported until the tightly folded 
DHFR•MTX complex reaches the OM, generating a stable import intermediate with the 
DHFR domain on the outside of the mitochondria. The Su9 domain spans both the OM 
and IM, and is held in place by the binding of mtHsp70 to the presequence residues 
exposed to the mitochondrial matrix. This system has been used previously to study the 
mitochondrial import pathway (Pfanner et al, 1987b; Vestweber et al, 1989; Ryan and 
Jensen, 1993).  However, by incorporating fluorescent dyes site-specifically into the 
Su9-DHFR construct, we will be able to examine the environment surrounding the 
modified residue as it is being imported. 
 Previous work in the Johnson lab has used modified lysine tRNAs to site-
specifically incorporate a fluorescent or photoreactive probe into the protein of interest.  
This approach would, in principle, place a modified lysine into any position denoted 
with a lysine codon.  But since the Su9-DHFR construct has 20 lysines, another method 
was required to allow incorporate only a single modified residue in each polypeptide.  
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The Johnson Lab had developed a system whereby amber suppressor tRNAs were 
charged with lysine, and the resultant Lys-tRNAamb were modified with the NBD 
moiety, generating εNBD-Lys-tRNAamb (Flanagan et al, 2003).  Site-directed 
mutagenesis could then be used to mutate the desired codon of an ORF to an amber 
codon, and translation of mRNAs transcribed from the mutated DNA construct would 
allow for incorporation of a modified residue only at the position of the amber codon.  
Another advantage of the suppressor tRNA system was that any full-length proteins 
generated would necessarily contain the probe on the modified lysine, because the only 
competition for the modified Lys-tRNAamb would come from endogenous termination 
factors that would release the nascent chain from the peptidyl-tRNA and thereby halt 
translation.  These prematurely terminated nascent chains would not have a fluorescent 
probe, so they would be invisible in the fluorimeter.  Hence, site-directed mutagenesis 
was performed on the Su9-DHFR construct to replace the codons for residues 8, 15, 20, 
25, 33, 40, 50, 60, 66, or 70 with an amber codon (one mutated position in each 
construct).  These constructs will hereafter be referred to as Su9-DHFR TAGX, where X 
is the number of residue mutated to an amber codon. 
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Figure III-1.  Translation of Su9-DHFR TAG mutants.  Su9-
DHFR TAG mutants were translated as described in 
Experimental Methods, in the presence of either [14C]Lys-
tRNAamb (t), or εNBD-[14C]Lys-tRNAamb (N). The position of 
each TAG is denoted on the figure.  The full- length Su9-
DHFR polypeptide is indicated by the closed circle (•).  With 
the exception of the TAG61 (<) and TAG70 (*) constructs, 
the prematurely-terminated polypeptides are too small to be 
seen on the on the gel.
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Incorporation of NBD into Su9-DHFR TAG Mutants 
 Labeling of the Su9-DHFR TAG mutants with the NBD probe relied on 
incorporation of the probe into the TAG position.  Figure III-1 shows some of the Su9-  
DHFR TAG mutants translated in the presence of either unmodified [14C]Lys-tRNAamb 
or εNBD-[14C]Lys-tRNAamb.  While the WT construct is translated even in the absence 
of the suppressor tRNAs, the TAG mutants are only translated in the presence of 
suppressor tRNA.  In addition, the presence of the NBD does not inhibit lysine 
incorporation.   
One other effect to be considered would be inhibition of import by the size of the 
fluorescent probe.  Previous work by Schwartz and Matouschek (1999) attempted to 
address the pore size of the TIM23 complex by importing matrix-targeted proteins 
labeled with gold particles of either 20 or 26 Å.  The precursor proteins with the 20 Å 
gold particles could be imported across the IM, while the precursor proteins labeled with 
the 26 Å gold particle were not.  The fluorescent dye NBD attached to the ε-carbon of 
the lysine side chain has a diameter much less than 20 Å, so import of NBD-Su9-DHFR 
polypeptides was not expected to be diminished, relative to unlabeled Su9-DHFR.  
When import of NBD-Su9-DHFR was tested by importing a radiolabeled Su9-DHFR 
TAG mutant that was translated in the presence and absence of εNBD-[14C]Lys-
tRNAamb and analyzing import efficiency via SDS-PAGE and autoradiography (Figure 
III-2), the presence of the NBD probe in the Su9-DHFR presequence only slightly 
inhibited import efficiency.  Hence, one can successfully generate import intermediates 
with the fluorescent-labeled Su9-DHFR constructs. 
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Figure III-2.  Su9-DHFR TAG mutants are imported in the 
presence of the NBD probe.  Su9-DHFR TAG mutants were 
translated and imported as described in Experimental 
Methods, in the presence of either [14C]Lys-tRNAamb (t), or 
εNBD-[14C]Lys-tRNAamb (N). 
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Generation of Mitochondrial Import Intermediates 
 Two methods for generating mitochondrial import intermediates are the use of 
DHFR•MTX, as has been done previously in the mitochondrial field, or the import of 
NBD-labeled nascent chains that are still bound to ribosomes to form ribosome•nascent 
chain complexes (RNCs), as has been done previously in the Johnson lab.  While the use 
of DHFR•MTX intermediates is the traditional method, generating import intermediates 
using RNCs, if successful, would have some important advantages.  This approach 
would require mutating only one position in the Su9-DHFR construct to an amber 
codon.  PCR would then be performed on the ORF to make DNA fragments of different 
lengths.  Transcription of these DNA fragments would generate truncated mRNAs (i.e., 
mRNAs lacking a stop codon).  Translation of these truncated mRNAs, results in the 
formation of RNCs because the ribosome will half at the end of the truncated mRNA.  
Since there is no stop codon, the nascent chain remains attached to the tRNA, and one 
creates an RNC sample in which all of the nascent chains have the same length (Crowley 
et al, 1994).  When these RNCs were added to a mitochondrial import reaction, the 
nascent chains would presumably be imported until the ribosome reached the TOM 
complex and halted further import.  As long as the nascent chain was long enough to 
cross both membranes and interact with mtHsp70 (~55 residues, Ungermann et al, 1994) 
a stable import intermediate would be generated.  By varying the length of nascent chain 
used in the reaction, one could position the single probe at different locations along the 
import pathway.  In the end, this approach was abandoned because of high fluorescence  
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Figure III-3.  Imports of Su9-DHFR into mitochondria in the 
presence and absence of methotrexate.  Radiolabeled Su9-
DHFR TAG15 was imported into mitochondria in the presence 
or absence of MTX, as described in Experimental Procedures.  
After import, the samples were split and either treated with 50 
µg/mL trypsin or left untreated.  p, precursor; m, mature.  Lane 
1 (1λ txl) refers to 1λ of the translation reaction, before 
addition of mitochondria.
1    2     3     4     5
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background signals, apparently due to NBD binding to the ribosome (Kenner and 
Aboderin, 1971), and despite many attempts to reduce this background.   
Therefore, it was decided to generate import intermediates using MTX binding to 
the DHFR domain.  Full-length Su9-DHFR TAG mutants were translated and then 
imported into mitochondria in the presence of 2 µM MTX.  The position of the NBD 
probe along the import pathway was therefore dictated by the location of the mutated 
residue in the polypeptide.  Because the Su9-DHFR•MTX complex can only be 
imported until the DHFR domain reaches the OM, the matrix processing protease (MPP) 
processing sites of the Su9 presequence (residues 33 and 66) do not reach the matrix-
side of the IM.  The extent of DHFR•MTX import intermediate formation can therefore 
be assayed by comparing the relative amounts of the mature and processed protein on an 
SDS gel (Figure III-3).  Any mature (processed) protein has to have been translocated 
into the matrix, and hence could not have been anchored by a folded DHFR domain at 
the TOM Complex.  But any protease-sensitive precursor (full-length) Su9-DHFR would 
have to have been trapped at the TOM complex by a folded DHFR•MTX domain.  To 
maximize and stabilize the formation of the tightly-folded DHFR conformation, MTX 
was used in all buffers subsequent to the import reaction.   
 
Preparation of Import Samples for the Fluorimeter 
 To evaluate an in vitro import reaction using fluorescence spectroscopy, the 
published import protocols had to be made changed.  For example, all necessary buffers 
and reagents had to be monitored for any contaminating materials that would scatter 
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light or emit fluorescent light at the wavelengths being monitored.  For this reason, 
sucrose was used instead of sorbitol to make the import reactions osmotically stable to 
the mitochondrial, because the sorbitol used for isolation of the mitochondria had too 
many fluorescent contaminants.  Malate and pyruvate were also chosen for the ATP-
regenerating system, instead of ATP and NADH, because NADH has been shown to 
quench NBD fluorescence (Hamman et al, 1997); thus, any extra NADH would decrease 
the signal intensity via collisonal quenching of the NBD probes.  Import reactions 
performed in the presence of 2 mM malate/pyruvate were as efficient as those performed 
in the presence of ATP/NADH (Fig III-4, compare lanes 1 and 6).  Finally, the amount 
of mitochondria in the import reactions was significantly lowered for the fluorescence 
experiments.  Mitochondria have significant autofluorescence, likely due to the electron 
transport complexes in the IM, and large amounts of mitochondria in the sample cuvettes 
resulted in inner filter effects and a decreased signal to noise ratio.  As shown in Figure 
III-5, decreasing the concentration of mitochondria in the import experiments from 1.0 
mg/mL (typical in vitro import conditions) to 0.02 mg/mL did not decrease the amount 
of imported preprotein because the amount of available TOM and TIM23 complexes 
were still not limiting.  
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Figure III-4.  Mitochondrial imports using different ATP-
regenerating systems.  Radiolabeled Su9-DHFR was imported into 
isolated mitochondria in the presence of ATP/NADH (A/N); 
NADH alone (N); ATP/TMPD (A/T); succinate (Suc); 
malate/pyruavte (M/P); or malate/succinate (M/Suc).  The 
concentrations used are listed below.  p, precursor; m, mature 
bands.
Mr 1      2       3        4       5       6       7       8 
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µg mitos/rxn     5     10   125   25    50  100
rxn size (µL)    50    50    50   100  100 100
p
m
14.3
18
29
43
68
97.4
200
Mr      1      2      3      4      5      6
Figure III-5.  Su9-DHFR imports into mitochondria using 
different amounts of membranes.  Su9-DHFR was translated, 
then the reaction was split and equal amounts of precursor 
protein were put into import reactions containing different 
amounts of mitochondria. p, Su9-DHFR precursor; m, mature 
protein.
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Once the import reactions had gone to completion, the import intermediates were 
purified from the rest of the reaction.  Traditionally, ER microsomes were purified away 
from the rest of the translation reaction using size-exclusion column chromatography.  
But the yeast mitochondria membranes could not be isolated using this same technique 
because a significant percentage of the mitochondria remained at the top of the column, 
probably because they were too large to enter the resin.  This reduced the yield of 
purified import intermediates, and hence the fluorescence signal of the purified sample.  
However, my attempts to use size-exclusion chromatography to isolate mitochondrial 
import intermediates did reveal the necessity of keeping an ATP-regenerating system in 
the mitochondrial buffers at all times.  Mitochondria isolated over a Sepharose CL-2B 
column (Sigma) were analyzed in the fluorimeter using the potentiometric dye JC-1.  
When the column buffer contained 2 mM malate, 2 mM pyruvate, and 2 mM KPO4 (pH 
7.4), the mitochondria maintained their membrane potential (∆Ψ) during the 
chromatography (Figure III-6, green triangles).  However, in the absence of this ATP-
regenerating system, the mitochondria became depolarized during chromatography 
(Figure III-6, blue diamonds).  A mitochondrial sample kept in a buffer lacking the 
malate, pyruvate, and KPO4, but not isolated using chromatography, was not depolarized 
(Figure III-6, red squares).  But the lower J-aggregate peak, compared to the 
mitochondria kept in the ATP-regenerating buffer, indicates a lowered membrane 
potential.  This was an important finding because maintenance of the population of 
import intermediates requires a stable membrane potential across the IM.   
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Figure III-6.  Emission scans of JC-1 fluorescence in the presence of 
mitochondria before/after column chromatography.  Mitochondria were 
collected before and after isolation with a CL-2B column, and then 
incubated with 1 ng/µL JC-1 as described in Experimental Procedures.  
Emission scans were taken at an excitation wavelength of 485 nm. Red 
squares, before column; blue diamonds, after column; green triangles, 
after column, in the presence of 2 µM each malate, pyruvate, and KPO4.  
The monomer and J-aggregate peaks are indicated. 
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The loss of the ∆Ψ allows the partially imported Su9-DHFR polypeptide to diffuse out 
of the mitochondrial IM and OM and back into the cytosol.   
In the end, the import intermediates were isolated via sedimentation rather than 
size exclusion chromatography.  The mitochondria were sedimented at speeds of about 
10,000g in a refrigerated centrifuge for 5 minutes.  This allowed the mitochondria to 
collect at the bottom of a microfuge tube in a loose pellet that could be easily 
resuspended into the SLM buffer.  After the first centrifugation step, the supernantant 
was aspirated and the mitochondria were washed in an SLM buffer containing 250 mM 
KOAc (pH 7.4) and 60 mM EDTA to release any adsorbed tRNA or preprotein from the 
OM.  The mitochondria were centrifuged again and resuspended in the final SLM buffer.  
Each resuspension buffer contained 2 mM malate, 2 mM pyruvate, 2 mM KPO4 (pH 7.4) 
and 2 µM MTX at all times.   
 
Characterization of Imported NBD-Su9-DHFR 
 Before any fluorescence data on the mitochondrial import intermediates could be 
collected and analyzed, certain experiments were necessary to characterize the state of 
the import intermediates in the fluorimeter.  As mentioned earlier, the isolated 
mitochondria and buffer components needed to be evaluated in the fluorimeter (SLM) 
for any background fluorescence or light-scattering material.  As seen in Figure III-7, the 
SLM Buffer, containing HEPES and sucrose, did not fluoresce significantly at the 
emission wavelength of 485 nm and the excitation wavelength of 530 nm.  The Import 
Buffer, containing both sorbitol and BSA, had a higher signal in the fluorimeter.  The 
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Figure III-7.  Emission scans of mitochondria and buffers.  Emission
scans of isolated mitochondria or buffers alone at the excitation 
wavelength of 468 nm.    , SLM Buffer;    , 0.05 mg/mL mitos in 
SLM Buffer;    Import Buffer;   , 0.05 mg/mL mitos in Import 
Buffer;    , 0.1 mg/mL mitos in Import Buffer.  
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mitochondria themselves had significant fluorescence intensity at these wavelengths, but 
since both the sample, containing the NBD-labeled Su9-DHFR, and the blank, 
containing the unlabeled preprotein, would have the same concentration of 
mitochondria, this background fluorescence could be subtracted from the sample 
fluorescence to obtain the net NBD emission.  The typical concentration of mitochondria 
in the cuvettes was around 0.15 mg/mL.   
 To determine the net NBD signal for the imported Su9-DHFR, two samples were 
prepared in parallel.  One, termed the Sample, contained the εNBD-[14C]Lys-tRNAamb in 
the translation reaction, and the other, termed the Blank, contained unmodified [14C]Lys 
tRNAamb.  The Sample and Blank would then be spectroscopically identical except for 
the presence of the NBD fluorophore.  After the translation, import, and isolation of the 
import intermediates, the Sample and the Blank were normalized with respect to the 
amount of light scattering material as described in Chapter II.  Fluorescence emission 
scans of the both the Sample and Blank were taken using an excitation wavelength of 
485 nm and scanning the emission from 490 – 600 nm.  By subtracting the emission scan 
of the blank from that of the sample the net NBD emission scan was obtained.  
To ensure that any NBD fluorescence observed was due to the presence of NBD 
in Su9-DHFR and not unincorporated εNBD-[14C]Lys-tRNAamb, emission scans were 
taken from mitochondria isolated from translation and import reactions performed in the 
presence and in the absence of Su9-DHFR mRNA.  As can be seen in Figure III-8, the 
NBD signal of mitochondria containing imported NBD-Su9-DHFR TAG50 or TAG75 
was around 2000 and 3500 pulses per second (pps), respectively. The NBD signal from 
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Figure III-8.  The NBD fluorescence of imported Su9-DHFR is due to 
incorporation of NBD into nascent chains. Su9-DHFR TAG50 (red), 
and TAG70 (blue) were translated in the presence of εNBD-[14C]Lys-
tRNAamb and imported into isolated mitochondria as described in 
Experimental Methods.  NBD emission scans were recorded using an
excitation wavelength of 468 nm.  An identical reaction, performed in 
the absence of any Su9-DHFR mRNA, showed no NBD fluorescence 
(green).  The spectra shown are the net NBD signals obtained after 
subtraction of the background signals of parallel samples lacking 
NBD.
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the mitochondria isolated from the translation/import reaction that lacked mRNA had 
negligible fluorescence, indicating that the NBD signal observed in the fluorimeter was 
indeed due to the presence of the NBD incorporated into Su9-DHFR. Differences in the 
fluorescence intensities of the different TAG mutants was likely due to the difference in 
the suppression efficiencies at each TAG position.  
The fluorescence signal of imported NBD-Su9-DHFR was observed as a 
function of time in the fluorimeter to detect whether any sedimentation of the 
mitochondria occurred during the course of a fluorescence experiment.  Mitochondria 
containing imported NBD-Su9-DHFR TAG25 were monitored using excitation and 
emission wavelengths of 468 nm and 530 nm, respectively, over the course of 60 
minutes.  Any significant sedimentation of the mitochondria would result in the 
membranes sinking below the light path in the SLM and would be evidenced as a 
decrease in the fluorescence signal.  However, no sedimentation of the mitochondria was 
observed (Fig III-9, blue solid line).  The sample lacking NBD (Blank) was also constant 
over time (Figure III-9, red solid line), indicating that the background intensity due to 
the mitochondria alone is also not reduced.  These results were significant because they 
meant that, for the fluorescence quenching experiments, any observed decrease in the 
signal would be due to collisions between fluorophore and quencher, and not to 
sedimentation of the mitochondria.   
Alamethicin is a pore-forming antibiotic that will form holes of around 16-20 Å 
in membranes containing a membrane potential (He et al, 1996), making it useful for 
forming pores in the mitochondria IM.  Upon addition of alamethicin the observed  
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Figure III-9.  Time dependence of imported NBD-Su9-DHFR 
emission.  NBD-labeled Su9-DHFR was imported into 
mitochondria and monitored in the fluorimeter over time at 
excitation and emission wavelengths of 468 nm and 530 nm, 
respectively.  Time traces were taken before and after treatment
with alamethicin (ALA) according to Experimental Procedures.  
,      Sample (+NBD);       , Sample after ALA treatment;      ,
Blank (-NBD);       , Blank after ALA treatment.
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signal increases slightly for both the Sample and Blank (Figure III-9, dashed lines).  
Since this phenomenon is seen for both the Sample (containing NBD) and the Blank 
(lacking NBD) it appears to be due to an effect of the alamethicin on the mitochondria 
themselves that results in an increase in the light scattering of the mitochondria.      
 
Evaluation of NBD Probes in the Mitochondrial Matrix 
 One of the goals of creating this fluorescence system was to evaluate the 
accessibility of a fluorescent probe to externally added NBD quencher.  When the NBD 
probe was placed along the TOM/TIM23 import pathway, any quenching by the 
quencher potassium iodide (KI) would indicate accessibility of the probe to the cytosol.  
These experiments would be performed on different amber mutants of Su9-DHFR to 
position the NBD probe at different locations along the import pathway.  As a first step, 
the initial experiments had to evaluate the accessibility of the NBD probe when the 
NBD-Su9-DHFR TAG mutant was fully imported into isolated mitochondria.  The 
iodide ions should not be able to cross the IM; therefore, fully imported NBD-Su9-
DHFR is expected to be inaccessible to externally added KI.  Indeed, Figure III-10 
shows only a small decrease in the NBD fluorescence of full length NBD-Su9-DHFR 
imported in the absence of MTX.  The residual quenching is most likely due to adsorbed 
NBD-Su9-DHFR proteins that were adsorbed to, but not imported into, the 
mitochondria, therefore not removed by the high salt wash.  To confirm this, the 
mitochondria were treated with Alamethicin to the KI access to the matrix.  Figure III-10 
shows that the NBD fluorescence is further decreased in the presence of alamethicin  
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Figure III-10.  Accessibility of imported NBD-Su9-DHFR to cytosolic 
KI.  NBD-Su9-DHFR TAG25 was fully imported into isolated 
mitochondria in the absence of MTX as described in Experimental 
Methods.  NBD emission scans were taken (ex. 468 nm) before (blue) 
and after (red) addition of 50 mM KI, and after addition of 7.5 µg/mL 
alamethicin (green).  
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because the KI can now quench the fully-imported NBD-Su9-DHFR.  This, it is possible 
to evaluate fully-imported NBD-Su9-DHFR in the fluorimeter, and, subsequently, to 
quench these fully-imported probes by KI after treatment of the mitochondria with 
alamethicin. 
 
Collisional Quenching of Fully Imported NBD-Su9-DHFR 
 Fluorescence quenching experiments were performed using NBD-labeled Su9-
DHFR TAG mutants that were imported in the absence of MTX.  In the absence of MTX 
the NBD-labeled preproteins would be fully imported into the mitochondrial matrix.  
Since the collisional quencher (here, iodide ions) cannot diffuse across the IM, the 
imported NBD-Su9-DHFR should be inaccessible to externally added KI.  Therefore, the 
fluorescence intensity in the presence of quencher (F) would not change much from the 
initial intensity in the absence of quencher (F0).  The Stern-Volmer equation for 
quantifying the extent of collisional quenching of fluorescent probes is: F0/F = 1 + 
Ksv[Q], where Q is the quencher concentration and Ksv is the Stern-Volmer quenching 
constant.  A small amount of quenching would result in a small change in F0/F, and 
hense in a low Stern-Volmer quenching constant (Ksv).   
An example of collisional quenching data for fully-imported Su9-DHFR TAG25 
in the absence of MTX is shown in Figure III-11, where KI was titrated to a final 
concentration of 72 mM.  As a control for the effect of increasing salt concentration on 
the imported NBD-Su9-DHFR, KCl was also titrated to a final concentration of 72 mM.  
Addition of KCl had only a minimal effect on the fluorescence intensity of the sample, 
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while addition of the quencher KI resulted in an increased amount of collisional 
quenching, and hence a higher F0/F ratio (Figure III-11, compare blue line and red line).  
The “net” Ksv is calculated by subtracting the KCl titration data from the KI titration 
data (Figure III-11, green line).  Alamethicin is added to both the samples titrated with 
KI and the samples titrated with KCl, and the net F0/F, after Alamethicin treatment, is 
calculated; however, since there is only one data point (at 72 mM KI/KCl) linear 
regression was not performed.  Figure III-11 shows that that after Alamethicin treatment, 
the (F0/F) increases compared to the value prior to Alamethicin treatment, indicating an 
increase in quenching by KI due to accessibility of the iodide ions to the NBD probes in 
the matrix. 
As can be seen in Table III-1, all of the Su9-DHFR TAG mutants have net Ksv 
values higher than zero.  These data indicate that some fraction of NBD-labeled 
substrates is adsorbed to the outside surfaces of the mitochondrial membranes and is 
therefore accessible to the externally added iodide ion quenchers.   
To minimize this adsorption phenomenon, a protease digestion was performed 
after the import step.  Upon incubating an import reaction with 50 µg/mL trypsin for 15 
min at 0°C prior to sedimenting the mitochondria for spectral analysis, initial Ksv 
constants were lower in some, but not all, cases  (Table III-1).  Since many of the 
experiments were performed with low fluorescence intensities, recorded as pulses per 
second (pps), it was difficult to obtain reproducible results.  The collisional quenching 
experiments recorded in Table III-1 each had a signal of greater than 1200 pps;  
 76
 
 
 
Figure III-11.  Matrix NBD-Su9-DHFR accessibility to KI.  NBD-
Su9-DHFR TAG61 was imported into isolated mitochondria in the 
absence of MTX and then exposed to either KI (blue) or KCl (red).  
The “net” accessibility to quenching by iodide ions was calculated 
by subtracting the KI data from the KCl data, and is shown in this 
graph in green.  Linear regression was performed on each data set, 
with the intercept set to equal 1, and the slopes of each line (the 
Stern-Volmer quenching constant, or Ksv) is recorded on the graph in 
the same color as the corresponding data/line.  After titration with KI 
or KCl, the samples were treated with 5 µg/mL alamethicin.  The net 
accessibility to quenching by iodide ions after alamethicin treatment 
is shown in orange.  Because only one point was recorded linear 
regression was not performed.
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Table III-1.  Stern-Volmer quenching constants for Su9-DHFR TAG mutants (- MTX)
    - Trypsin
TAG nb ppsa Ksv, I (M
-1)* Ksv, Cl (M
-1)* Ksv net (M
-1)*
25 3 4400 4.4 +/- 0.5 2.0 +/- 0.7 2.6 +/- 0.9
33 5 2900 4.4 +/- 0.5 1.8 +/- 0.6 2.8 +/- 0.6
50 2 3300 3.1 +/- 0.8 0.5 +/- 0.5 2.5 +/- 0.2
61 3 4050 3.2 +/- 0.5 1.2 +/- 0.5 1.8 +/- 0.8
70 1 2400 1.5 -0.2 1.6
    + Trypsin
TAG nb ppsa Ksv, I (M
-1)* Ksv, Cl (M
-1)* Ksv net (M
-1)*
40 4 3100 2.5 +/- 0.5 0.6 +/- 0.7 1.8 +/- 1.0
61 1 1700 1 0.3 0.3
a pps: pulses per second, averaged over n repetitions
b n, number of repetitions
* Reported as averages, standard deviations over n repetitions
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quenching experiments with intensities of less than 1200 pps were not included, since 
the signals were too low to obtain reproducible quenching data.   
 
Collisional Quenching of Su9-DHFR Import Intermediates 
 Fluorescence quenching experiments were also performed for NBD-Su9-DHFR 
imported in the presence of MTX, both with and without a trypsin digestion of the 
import intermediates prior to spectral analysis (Table III-2).  For the quenching 
experiments performed in the presence of MTX, and without a trypsin digestion prior to 
spectral analysis, the net Ksv values are similar for all of the TAG constructs, and all 
higher than zero, indicating a population of NBD-Su9-DHFR polypeptides is adsorbed 
to the mitochondria.  For the quenching experiments performed in the presence of MTX 
and with a trypsin digestion prior to spectral analysis, the net Ksv values are generally 
lower.  However, some constructs have data for only one experiment, since experiments 
with fluorescence signals less than 1200 pps were not included in the data set.  Some of 
the data for the constructs gather under conditions where the NBD-Su9-DHFR was 
imported in the presence of MTX and was subjected to a trypsin digestion indicated 
negative net Ksv values as well, such as the TAG50 and TAG70 construct.  These results 
are most likely due to small fluorescence intensities.  More repetitions, performed on 
samples with higher intensities, would allow for a more accurate net Ksv value to be 
obtained. 
However, data interpretation is complicated for the Su9-DHFR import 
intermediates by the fact that there are multiple populations of NBD-Su9-DHFR nascent 
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Table III-2.  Stern-Volmer quenching constants for Su9-DHFR TAG mutants (+ MTX)
    - Trypsin
TAG nb ppsa Ksv, I (M
-1)* Ksv, Cl (M
-1)* Ksv net (M
-1)*
25 4 3000 3.1 +/- 0.9 0.9 +/- 0.5 2.1 +/- 0.7
50 3 1800 3.3 +/- 2.7 1.1 +/- 0.4 2.2 +/- 2.2
61 2 3750 4.5 +/- 1.6 2.0 +/- 0.3 2.4 +/- 1.0
    + Trypsin
TAG nb ppsa Ksv, I (M
-1)* Ksv, Cl (M
-1)* Ksv net (M
-1)*
40 2 2150 2.6 +/- 1.6 1.7 +/- 0.4 0.1 +/- 1.1
50 1 2400 1.8 2 -0.2
61 1 1300 4.4 2.8 1.8
70 1 1900 1.6 3.4 -3.8
a pps: pulses per second, averaged over n repetitions
b n, number of repetitions
* Reported as averages, standard deviations over n repetitions
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chains.  As seen in Figure III-3, there is a small population of mature, imported Su9-
DHFR, even in the presence of MTX, though most proteins are trapped at the TOM 
complex.  After trypsin digestion, the amount of precursor protein is diminished, but two 
populations of Su9-DHFR nascent chains still exist – the import intermediates, bound by 
MTX, and the mature protein, not bound to MTX.  The fate of the NBD- labeled 
presequences removed by MPP is unknown, but it is presumed that the NBD probes 
remain inside the mitochondrial matrix.  Because there are NBD-Su9-DHFR 
polypeptides both bound as import intermediates and fully imported, their accessibilities 
to the KI quencher may differ.  If they do, the observed fluorescence signal will reflect 
the weighted molar averages of the quenching experienced by the two populations. 
It is possible, however, to compare overall Ksv results for the Su9-DHFR TAG 
mutants in the presence and absence of MTX.  For the Su9-DHFR TAG61 construct, the 
overall Ksv value is around 0.3 M-1 in the absence of MTX (fully imported), and is 
around 1.8 M-1 in the presence of MTX (import intermediate).  The overall Ksv is also 
lower for the TAG40 import intermediate (0.1 M-1), compared to the fully imported 
construct (1.8 M-1).  However, the average Ksv values for all of these constructs are 
within one standard deviation, so the –MTX and +MTX results are most likely not 
statistically different from each other.  This would suggest that the NBD probes placed 
along the import pathway during the experiments +MTX are no more accessible to 
externally-added iodide ions that the probes fully imported into the matrix in the absence 
of MTX.  More repetitions, with more TAG positions, would be required to verify this 
supposition. 
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Evaluation of the Environment of the NBD probe in the 
Su9-DHFR Import Intermediates 
 After each fluorescence quenching experiment is completed, the samples are 
analyzed for the amount of [14C] radioactivity to determine the number of NBD probes 
contained in each sample.  A ratio is calculated between the observed net fluorescence 
intensity (pulses per second, pps) and the radioactivity (counts per minute, cpm), 
referred to as the pps/cpm ratio, that provides an indication of the environment of the 
NBD probe.  When two different experiments have similar pps/cpm ratios, the NBD 
probes are likely in the same environment.  The average pps/cpm ratios for the NBD-
Su9-DHFR TAG mutants are listed in Table III-3.  Since the pps/cpm ratios for various 
mutants are very similar, it appears that for each construct the NBD probe is in the same 
environment in each intermediate.  The pps/cpm ratios for the different NBD-Su9-DHFR 
TAG mutants were higher than that of the εNBD-[14C]Lys-tRNAamb, as well as for the 
εNBD-[14C]Lys after hydrolysis away from the tRNA moiety.  The lower pps/cpm ratio 
for the NBD probe while attached to the tRNA is most likely due to an alteration in NBD 
spectral properties caused by the stacking of the NBD ring and tRNA bases.  Hydrolysis 
of the NBD probe away from the tRNA resulted in a higher pps/cpm ratio, although it is 
still not as high as for the NBD-Su9-DHFR TAG mutants.  The most likely reason for 
this discrepancy is the possibility that there are NBD probes in different environments 
(aqueous and nonpolar) for both the fully-imported (-MTX) and intermediate (+MTX)  
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Table III-3.  Pps/cpm ratios for Su9-DHFR TAG mutants
TAG MTX nb pps/cpma
25 + 4 5.7 +/- 0.9
- 4 5.2 +/- 0.1
33 + 5 5.3 +/- 1.0
- - -
40 + 2 4.2 +/- 0.7
- 4 4.2 +/- 1.8
50 + 3 5.4 +/- 0.3
- 2 3.8 +/- 2.6
61 + 2 5.8 +/- 0.1
- 7 5.7 +/- 0.5
70 + 1 5.6
- 2 3.7 +/- 0.9
NBD-[14C]Lys tRNAamb,c 2 1
NBD-[14C]Lysd  1 2
a Pps readings were taken at excitation and emission wavelengths of   
468 nm and 530 nm, respectively. After spectral measurements were taken,
50% of sample was removed, added to a Triton-based scintillation cocktail,
and counted using a liquid scintillation counter.
b number of repetitions
c NBD-[14C]Lys-tRNAamb was diluted into SLM Buffer 
 intensity read as for the NBD-Su9-DHFR readings.  100% of the sample 
was removed, added to a Triton-based scintillation cocktail, and counted
as above.
d Treated the same as in c, except the NBD-[14C]Lys was 
hydrolyzed from the tRNA by heating at 37 C for 1 h prior to spectral analysis.
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NBD-Su9-DHFR polypeptides.  The resultant pps/cpm ratio is a weighted average of the 
probes in an aqueous environment, which have a low pps/cpm ratio (Crowley et al, 
1993) and the probes in a nonpolar environment, which have a high pps/cpm ratio.  
Without the use of fluorescence lifetime analysis to determine the molar fraction of NBD 
probes in each environment, we cannot assess the distribution of NBD probes in aqueous 
or nonpolar environments.  Previous electrophysiological and cryo EM data suggest that 
Tim23 forms an aqueous channel (Truscott et al, 2001), but no experiments have 
examined the environment of protein substrates except for the above fluorescence 
measurements.  But while the data summarized in Table III-3 indicate that the NBD 
environments do not change significantly at different locations along the import pathway 
before or after being fully imported, further experiments will be necessary to accurately 
characterize probe locale. 
 
Location of Su9-DHFR Probe Positions Along the Import Pathway 
 To identify the location of each Su9-DHFR TAG mutant along the import 
pathway, chemical crosslinking was employed.  Su9-DHFR Cys mutants were translated 
and imported into isolated mitochondria as described in Experimental Methods, and then 
treated with the homobifunctional cysteine-cysteine crosslinker BMH.  The BMH will 
create a covalent bond between the cysteine residue in the Su9-DHFR construct and any 
cysteine residue of a neighboring protein that is within reach of the 16 Å BMH spacer 
arm.  Figures III-12 and III-13 show the BMH crosslinking data for the WT Su9-DHFR 
as well as the Cys mutants 8, 20, 25, 40, and 60.  The WT construct, which contains only 
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the native cysteine residue at position 79, appears to form a prominent covalent adduct 
with a molecular mass near 60 kDa in both the presence and absence of MTX (Figure 
III-12, lanes 3 and 5).  This same covalent adduct is seen for each Su9-DHFR TAG 
construct (marked in each lane with a >) and is most likely an artifact caused by 
radioactive material being washed ahead of the relatively large bolus of proteins in the 
gel at that location.   
However, different crosslinking patterns were observed for the Su9-DHFR Cys 
mutants, indicating that the formation of the covalent adducts seen depends on the 
location of the second cysteine residue in the Su9-DHFR polypeptide.  The Su9-DHFR 
constructs with cysteines at positions 8, 25, 40 and 60 all form a large molecular mass 
adduct of approximately 85 kDa (Figure III-12, lanes 8 and 10; Figure III-13, lanes 3, 5, 
8, 10, 13, and 15, marked with an asterisk).  By subtracting the molecular weight of the 
Su9-DHFR construct (approximately 30 kDa), the molecular mass of the adduct is 
estimated to be near 55 kDa.  This common crosslinking target is most likely Tim50, a 
protein thought to be near substrates importing using the TIM23 Complex.  The Su9-
DHFR Cys8 construct also shows other crosslinking adducts seen for both the +MTX  
and –MTX reactions, of sizes 125 kDa, 72 kDa, and 50 kDa (Figure III-12, lanes 8 and 
10, marked with ^, •, and °, respectively).  
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igure III-12.  Chemical crosslinking of Su9-DHFR Cys8 and Cys20.  Su9-DHFR 
ys mutants were translated, imported, and reacted with BMH as described in 
xperimental Methods.  Each crosslinking reaction was performed in the presence 
d absence of MTX.  The construct used for the reaction is indicated below the 
appropriate lanes.  1λ refers to the amount of the translation reaction loaded directly 
to the gel.  The > identifies a background band that appears in every lane 
containing BMH (lanes 3, 5, 8, 10, 13, and 15).  For the Su9-DHFR Cys8 construct, 
any covalent adducts are seen in lanes 8 and 10.   The bands marked with a ^ 
denote a covalent adduct of around 125 kDa, while the bands marked with an * 
denote a larger covalent adduct of around 85 kDa.  Smaller covalent adducts 
arked with • and ° have molcular masses of around 72 kDa and 50 kDa, 
spectively.  For the Su9-DHFR Cys20 construct in the absence of MTX, a 
covalent adduct with a molecular mass of 40 kDa is seen (in lane 13, marked with 
 x).  p, Su9-DHFR precursor; i, Su9-DHFR intermediate form; m, Su9-DHFR 
ature form.
Mr 1    2    3    4     5    6    7    8    9   10   11   12  13  14  15
14
30
46
66
97
220
p
i
m
>> > > > >
**
F
C
E
an
on
m
m
re
an
m
x
^^
•
°°
•
 
  
 86
1λ - +     - +    1λ - +      - +    1λ - +    - +  BMH 
- +                 - +                    - +      MTX
C25                               C40             C60
1    2    3    4     5     6    7     8    9   10   11  12  13 14  15  Mr
14
30
46
66
97
220
> > > >> >
******
+ +
x x
p
i
m
Figure III-13.  Chemical crosslinking of Su9-DHFR Cys25 and Cys40, and 
Cys60.  Su9-DHFR Cys mutants were translated, imported, and reacted with 
BMH as described in Experimental Methods.  Each crosslinking reaction 
was performed in the presence and absence of MTX.  The construct used for 
the reaction is indicated below the appropriate lanes.  1λ refers to the 
amount of the translation reaction loaded directly onto the gel. The > refers 
to a background band that appears in every lane containing BMH (lanes 3, 5, 
8, 10, 13, and 15).  The bands marked with an asterisk in lanes 3, 5, 8 , 10, 
13 and 15 denote a covalent adduct also seen for each construct, with a 
molecular mass of 90 kDa.  The bands marked with a X in lanes 13 and 15 
denote a covalent adduct of around 40 kDa seen for the Su9-DHFR Cys60 
construct. A covalent adduct of around 46 kDa is seen for the Su9-DHFR 
Cys25 construct (lanes 3 and 5, marked with a +).  p, Su9-DHFR precursor; 
i, Su9-DHFR intermediate form; m, Su9-DHFR mature form.
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  Other crosslinking adducts vary with the position of the second cysteine.  A 
covalent adduct of around 46 kDa was seen for the Su9-DHFR Cys25 construct, both in 
the presence and absence of MTX (Figure III-13, lanes 3 and 5, marked with a +).  After 
correcting for the molecular mass of the Su9-DHFR precursor, the mass of the adduct is 
around 16 kDa, which could indicate that the identity of the adduct is Tim17, another 
component of the TIM23 complex.  A small covalent adduct of approximately 42 kDa is 
observed for Su9-DHFR Cys60 (Figure III-13, lanes 13 and 15 (marked with an x)), but 
not for the other constructs.  After correcting for the molecular mass of the Su9-DHFR 
precursor, the mass of the adduct is estimated to be around 12 kDa, suggesting the 
identity of the adduct could be Tim14/Pam16, an IM member of the PAM Complex. 
Immunoprecipitations against TOM, IMS, and TIM23 components will be required to 
identify the crosslinking targets.  
It should be noted that several of the covalent adducts do not appear to be 
dependent on the presence of MTX (i.e., the presence of import intermediates). 
However, the presence of an intermediate band, denoted with an i in Figures III-12 and 
III-13, is seen for all imported constructs, even in the absence of MTX.  This 
intermediate band is seen when the Su9-DHFR construct is only imported into the matrix 
far enough for the first MPP site to be cleaved.  Since these Su9-DHFR polypeptides are 
not completely imported (that is, they have not reached the mature length), it seems 
likely that they constitute a population of import intermediates that might crosslink to the 
TOM and TIM23 import components.   
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While the lack of MTX dependence in the chemical crosslinking results is 
disconcerting, in some respects it correlates with previous data showing the relatively 
small fraction of Su9-DHFR that is bound by MTX in a trypsin-resistant fashion (see 
Figure III-3, lane 3).  The fact that for each import reaction the fraction of Su9-DHFR 
processed to the mature (m) form is less in the presence of MTX than in the absence of 
MTX indicates that the MTX is binding a portion of the translated Su9-DHFR 
polypeptides.  Since such a small amount of the mitochondria-associated Su9-DHFR is 
forming MTX-bound import intermediates the observed crosslinking efficiency would 
be expected to be very low.  The crosslinking bands seen in Figures III-12 and III-13 are 
likely the result of the Su9-DHFR intermediate (i) population, which appear to remain 
constant in the presence and absence of MTX.  However the import intermediates are 
formed, it does follow that the pattern of chemical crosslinking with BMH does change 
with different Su9-DHFR Cys mutants, indicating that the covalent adducts seen are 
dependent on the location of the second cysteine residue.   
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CHAPTER IV 
CONCLUSIONS 
 
 The experiments performed in this thesis revealed that it is possible to use 
fluorescence spectroscopy to examine protein import into mitochondria.  First, it was 
found that an NBD fluorescent probe could be site-specifically incorporated into the 
model matrix protein Su9-DHFR using the amber suppressor tRNA system developed in 
the Johnson lab (Flanagan et al, 2003).  Second, in vitro import experiments revealed 
that the presence of the NBD probe on the preprotein does not interfere with the ability 
of the preprotein to be efficiently imported into the mitochondrial matrix.  Third, 
fluorescence collisional quenching experiments revealed that the NBD-Su9-DHFR 
preproteins fully imported into the mitochondrial matrix are inaccessible to externally-
added iodide quencher, but can be quenched by the iodide ions after the mitochondria 
are treated with the pore-forming antibiotic alamethicin.  Fourth, Su9-DHFR import 
intermediates could be generated with the NBD-Su9-DHFR preproteins using the folate 
analog methotrexate, and these import intermediates could also be using for collisional 
quenching experiments.  Fifth, the environment of the NBD probe, as evaluated by the 
pps/cpm ratio, does not appear to vary with the position of the NBD probe along the 
import pathway.  The pps/cpm ratio was also the same for each probe position both as an 
import intermediate and as a fully imported protein in the mitochondrial matrix.  Taken 
separately, each one of these statements reflects a small step towards setting up the 
mitochondrial import system for fluorescence analysis.  However, taken together, these 
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data show that it is possible to analyze mitochondrial import via fluorescence techniques.  
Further, site-specific incorporation of a fluorescent probe into the Su9-DHFR preprotein 
allows for the possibility of examination of a specific location along the import pathway, 
such as the TOM complex or the TIM23 complex. 
One of the two main difficulties that arose while adapting the mitochondrial 
import system for fluorescence studies was low signal intensity.  In vitro mitochondrial 
import is, on average, about 30% efficient, which means that about 30% of the translated 
preproteins are actually processed to their mature form.  Since there is only one NBD 
probe per preprotein, this low import phenomenon results in a small amount of 
fluorescent probes fully imported into the mitochondria.  Also, the mitochondria 
themselves contain a lot of background fluorescence, which further decreases the signal 
to noise ratio.  Many different optimizations were attempted to either boost the signal, by 
further increasing in vitro import efficiency, or lower the noise, by limiting the amount 
of mitochondrial protein in the sample cuvettes, but no significant effects were seen with 
respect to higher fluorescence intensity.  Import experiments using a different 
fluorescent probe were also attempted.  The [14C]Lys-tRNAamb was modified with the 
BODIPY fluorophore (4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene, Molecular Probes).  
The BODIPY probe has a high quantum yield, and hence a relatively high fluorescence 
intensity per probe.  However, it was found to be impractical to use the probe for 
collisional quenching experiments because very little suppression of the Su9-DHFR 
TAG mutants was observed due to the larger size of BODIPY than of NBD.  The 
BODIPY probe is also not very environmentally sensitive; thus, we could not use this 
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probe to measure the environment (aqueous or nonpolar) of the preprotein during import.  
To increase the signal to noise ratio of the Su9-DHFR import intermediates, one option 
is to overexpress and purify Su9-DHFR from E. coli.  This purified Su9-DHFR could 
then be labeled with NBD, and a higher concentration of purified NBD-Su9-DHFR 
could be used in import incubations.  This technique of importing overexpressed protein 
has been used before (Dembowski et al, 2001) and it may provide a viable alternative to 
importing in vitro-translated Su9-DHFR.   
The second primary difficulty in doing the fluorescence quenching experiments 
with Su9-DHFR import intermediates was interpreting spectral data from samples 
containing mixed populations of precursor and mature protein.  As mentioned briefly in 
Chapter III, after importing the Su9-DHFR TAG mutants into mitochondria in the 
presence of MTX, three different populations were generated:  the import intermediates, 
which were bound by MTX and which spanned the OM and IM; the fully imported and 
processed DHFR, which was not bound to MTX; and the Su9-DHFR preproteins 
adsorbed to the outside of the mitochondria, which might or might not be bound to 
MTX.  While a mild trypsin digestion reduced the number of adsorbed nascent chains, 
two populations still remained, and often the fraction of Su9-DHFR import intermediates 
was small, compared to that in the matrix.  These mature proteins no longer contain the 
NBD-labeled Su9 presequence, and the fate of the presequences after processing by 
MPP is as yet unknown.  Thus, analysis of the spectral data is further complicated by 
uncertainty about the location of released fluorescent presequences. Since different 
probe populations may have different accessibilities to the externally added iodide ion 
 92
quenchers, ascertaining the extent of iodide ion quenching of individual species is 
difficult.  Accurate interpretation of collisional quenching, fluorescence lifetime, and 
other spectral data require either a homogeneous population of import intermediates, 
which we were unable to achieve, or a means to establish biochemically the distribution 
of fluorophores among different locations or structural states (Johnson, 2005). 
Despite this disappointment, the body of work contained in this thesis constitutes 
the first evidence that using fluorescence spectroscopy to analyze protein import into 
isolated mitochondria is feasible.  Further optimizations of the import conditions, such as 
the length of Su9 presequence, possible overexpression of the Su9-DHFR preprotein, 
and a “better” fluorescent probe that is efficiently incorporated into the preprotein and 
has a higher quantum yield than NBD, might allow the original specific aims of the 
project to be fulfilled.  Another possibility, now that the import conditions are optimized 
for fluorescence analysis, would be to perform imports of a fluorescent-labeled 
translocase component, such as mtHsp70, or Tim23, and analyze its interactions with the 
other components of its translocase by changes in the lifetime of the fluorophore, its 
ability to be collisionally quenched by an externally-added quencher, or even its 
proximity to another fluorescent-labeled component (FRET analysis).  All of these 
possibilities are conceivable, based on the viability, shown here, of importing a 
fluorescent preprotein into mitochondria. Despite the experimental challenges that 
remain, this spectroscopic approach will ultimately contribute significantly to our 
understanding of mitochondrial protein import pathways. 
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